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ABSTRACT 
Diabetes Group Medical Visits and Biophysical Outcomes of Care in Uninsured Persons with 
Diabetes 
Jennifer A Mallow 
 
Background:  Rural populations with low socioeconomic status are at higher risk of late 
diabetes diagnosis, poor diabetes control, decreased self-management, and development of 
complications. Diabetes Group Medical Visits (DGMVs) have been used to improve outcomes 
for persons with diabetes. A gap in the literature exists related to the effectiveness of DGMVs for 
uninsured persons with diabetes.  
Aims: The aims of the study were to describe the characteristics of uninsured persons with 
diabetes cared for in a free clinic, describe the biophysical outcomes of care, explore the 
differences in biophysical outcomes of care before and after attending DGMVs versus receiving 
usual care, and explore the impact of dose of DGMVs on biophysical outcomes of care. 
Methods: This retrospective study was conducted at a free clinic in West Virginia, using chart 
review of a convenience sample of patients following approval of the WVU IRB. The inclusion 
criteria were: 1) age > 18 years, 2) diagnosis of diabetes, 3) uninsured and received care at a free 
clinic between May 2007 and August 18, 2009. A total of 111 patients were studied. There were 
53 participants who attended DGMVs and 58 participants who received usual care. Statistical 
Package of Social Sciences (SPSS), version 18 was used for analysis of the data. 
Results: The majority of the patients were female, white, severely obese, had a high-school 
education or less, were age 50 or younger, had a mean of 5 co-morbid conditions other than 
diabetes, and drove long distances to receive care. The patients who attended DGMVs had a 
higher HgA1C, reported more pain, had increased depression levels and were more obese at 
baseline than those who received usual care. There was a statistically significant decrease in 
  
systolic blood pressure from time one to time two in patients who attended DGMVs. There was 
no significant impact on biophysical outcomes of care in patients who received usual care from 
time one to time two. Dose of DGMVs did not impact biophysical outcomes of care. 
Conclusion: DGMV as an intervention is not enough to improve biophysical outcomes in this 
population. Interventions targeted to the unique characteristics of this population are needed to 
prevent devastating complications.  
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CHAPTER 1: INTRODUCTION 
Diabetes mellitus is one of the major causes of morbidity and mortality in the United 
States with 1.6 million new cases diagnosed in people 20 years or older every year (Centers for 
Disease Control, 2007). If poorly managed, diabetes increases an individual’s risk of lifelong 
health complications including blindness, chronic kidney disease, lower-limb amputations, 
peripheral neuropathy, decreased quality of life, decreased functional status, and emotional 
distress (Prevention, 2007). In 2007, the Centers for Disease Control estimated that diabetes cost 
the United States $174 billion in both direct and indirect medical costs (Centers for Disease 
Control, 2007). It is estimated that nearly 23.6 million people have diabetes in the United States 
(Centers for Disease Control, 2007).  
Data collected from the 2008 Behavioral Risk Factor Surveillance System (BRFSS) 
indicate that 14.7 percent of Americans are uninsured (Prevention, 2007). According to the 2006 
National Health Information Survey (NHIS), 16.5% of persons with diabetes reported that they 
needed medical care and did not receive it due to cost. Uninsured adults with diabetes 
predominantly have low incomes, are members of minority groups, and receive fewer preventive 
services than those with health insurance (Ayanian, Weissman, Schneider, Ginsburg, & 
Zaslavsky, 2000). Hence, diabetes is a significant problem for the uninsured because untreated 
diabetes can lead to devastating consequences.  
Diabetes mellitus accounts for a significant proportion of the care provided by primary 
health care providers (Mazze RS, 1994). Due to the complexities of managing diabetes, the 
American Diabetes Association (ADA) offers a foundation by which providers direct their 
medical treatment. Despite increasing provider knowledge, advancing treatment options, and 
providing countless educational programs, adherence to treatment regimens continue to be less 
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than optimal (SERVICES, Prevention, & Statistics, 2008). The treatment of diabetes is 
dependent not only upon knowledge and awareness of the provider, but on the knowledge, 
awareness, and situation of the patient (Barud, Marcy, Armor, Chonlahan, & Beach, 2006). 
Current theoretically based research supports that provider approach is a key component 
affecting diabetes management. However, research supports that patient education, 
socioeconomic factors, and amount of social support may also affect diabetes management 
(Maddigan, Majumdar, & Johnson, 2005). Substantial expenditure of healthcare dollars is 
incurred by people with diabetes. Resources could be saved by a reduction in diabetes co-
morbidities and complications. Reduction in resource use could be accomplished through 
improved diabetes care and outcomes. Cost-effective programs need to be initiated to maximize 
health gains for patients and to reverse the advance of this epidemic in society (Ryan, 2009). 
Specifically, peer support has been suggested to have the potential to provide a culturally 
appropriate exchange of resources between patients, aimed at increasing the well-being of the 
recipient of care (van Dam et al., 2005). Group medical visits, a type of peer support, have been 
used in recent years to improve the process of providing care and to improve outcomes for 
patients. However, there is a considerable gap in current knowledge about the effectiveness of 
Diabetes Group Medical Visits (DGMVs) especially related to the dose of visits needed to 
impact outcomes. 
Significance 
 DGMVs have the potential to positively affect outcomes of care for those who are uninsured 
(Clancy, Brown, Magruder, & Huang, 2003; Trento et al., 2002; Wagner et al., 2001). Little is known 
about the characteristics of uninsured persons with diabetes, who attend or will benefit from group 
visits, and the dosage of group visits that is needed to affect outcomes of care. Group visits may 
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offer more intensive care to uninsured individuals by clustering care and providing peer support 
during the visit.  
Patients have reported that group visits are an acceptable form of health care, and  
minority populations have found that group visits are culturally relevant (Keyserling et al., 
2000). Research has documented that persons with diabetes who participate in group visits had 
increased satisfaction with care, interaction with providers, diabetes knowledge, education, 
quality of life, preventive procedures and screenings (Wagner et al., 2001; Trento et al., 2001). 
Clinical outcomes associated with group visits in persons with diabetes have been documented to 
include: decreased or stable HgA1C, decreased cardiovascular risk, decreased or stable BMI, 
decreased LDL, increased HDL, decreased or stable blood pressure and slowed progression of 
retinopathy (Wagner, et al., 2001). All of these positive clinical outcomes were achieved with an 
increase in provider trust and a decrease in or more effective use of provider time (Clancy et al., 
2003). However, the dosage of DGMVs that may affect outcomes of care is unknown.  
This proposed study will attempt to increase knowledge related to the effect of DGMVs on 
those who are uninsured, the dosage of DGMVs that may affect outcomes of care, and how 
biophysical outcomes of care are impacted by DGMVs. This knowledge can potentially impact 
practice, resource utilization, and research for the future.  
Aims 
The purpose of this descriptive, correlational study was to analyze the relationship 
between attendance at Diabetes Group Medical Visits (DGMV) and biophysical outcomes of 
care in uninsured persons with diabetes who are cared for in a free clinic. Specifically the aims of 
this study will be: 
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1. To describe the characteristics of uninsured persons with diabetes who are cared for in a 
free clinic. 
2. To describe the biophysical outcomes of care in uninsured persons with diabetes who are 
cared for in a free clinic. 
3. To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and one year after attending DGMVs. 
4. To compare biophysical outcomes of care in uninsured persons with diabetes who receive 
usual care in a free clinic at baseline and after one year. 
5. To analyze the differences in biophysical outcomes in persons with diabetes who attend 
DGMVs versus those who receive usual care in a free clinic at base line and then again 
after one year.  
6. To analyze the differences in characteristics of uninsured persons with diabetes who are 
attendees of DGMVs versus those who receive usual care. 
7. To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured 
persons with diabetes who receive care in a free clinic after one year.  
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CHAPTER 2: REVIEW OF LITERATURE 
The purpose of this chapter is to explore the literature related to Diabetes Group Medical 
Visits (DGMVs) and biophysical outcomes of care. First, the Quality Health Outcomes Model 
(QHOM), the theoretical framework guiding this study, will be presented. Then, the QHOM will 
be used as a guide to present the current empirical literature related to DGMVs and biophysical 
outcomes of care for persons with diabetes.  
Conceptual Framework: Quality Health Outcomes Model 
The theoretical framework guiding this study is the Quality Health Outcomes Model 
(QHOM). The QHOM was developed by the American Academy of Nursing’s Expert Panel on 
Quality Health Care in 1996 as an expansion of Donabedian’s structure-process-outcome 
framework. The QHOM is a more dynamic framework that acknowledges the feedback that 
occurs between patients, the system or context in which care is provided, and interventions 
(Mitchell, Ferketich, & Jennings, 1998). This model links outcomes to the interactions of 
patients and the healthcare system with healthcare interventions intended to treat the individual, 
family, or community (Mitchell, Heinrich, Moritz, & Hinshaw, 1997). The four major concepts 
included in this model are: system, interventions, patients, and outcomes. These concepts have 
reciprocal connections, except for interventions and outcomes. Factors that may affect patient 
outcomes include the three major concepts of the QHOM: system, interventions, and patient 
characteristics (see Figure 1). Interventions affect and are affected by both system and patient 
characteristics in producing desired outcomes.  
The QHOM guides the identification of factors contributing to patient outcomes, which is 
the focus of this study. The model posits that outcome measures are the result of care structures 
that integrate functional, social, psychological, physical and physiologic aspects of people’s 
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experience in health and illness. The model further proposes that such outcome measures should 
be operationalized in five categories: achievement of appropriate self-care, demonstration of 
health-promoting behaviors, health-related quality of life, perception of being well-cared-for, and 
symptom management (Mitchell, et al., 1998).  
The purpose of this study was to analyze the relationship between attendance at Diabetes 
Group Medical Visits (DGMVs) and biophysical outcomes of care in uninsured persons with 
diabetes who are cared for in a free clinic. The QHOM is used as the theoretical underpinning for 
this study. Therefore, the literature will be reviewed and presented by the major concepts of the 
QHOM: intervention, patient characteristics, and outcomes of care.  
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Figure 1:  Quality Health Outcomes Model 
 
 
 
 
 
 
(Mitchell, et al., 1998)  
8 
 
   Literature Review 
In this section the empirical literature related to DGMVs will be reviewed. In order to 
complete the review, three computerized databases (Pubmed, Medline, and CINAHL) were 
searched using the key words of diabetes, peer support, social support, support groups, group 
visits, quality health outcome model, chronic care model, cooperative health care clinics, and 
drop-in group medical appointments. Limits were set for articles published in the English 
language. A total of 624 articles were identified that met these requirements. Group medical 
visits have only emerged as a treatment option for persons with diabetes over the past decade. 
Hence, limits were set for articles published in the last ten years. Limits for empirical literature in 
outpatient settings were also added. In addition, the bibliographies of these studies, as well as 
review articles on adherence, were examined for additional references. Review articles, 
editorials, and practice models were not included. Using these limits a total of 37 articles were 
reviewed.  The quality of the articles was evaluated by using the Rosswurm & Larrabee critique 
guidelines (Rosswurm & Larrabee, 1999). The data abstraction was completed systematically by 
the author using a matrix system.  
System Characteristics  
System characteristics are traditional structure and process elements of organizations, 
such as size, ownership, skill mix, and technology. There are three levels of system 
characteristics including individual, group, and organizational levels. The system characteristics 
in the QHOM are considered to directly affect and be affected by patient outcomes. The system 
characteristics are the mediators of patient characteristics and interventions in producing patient 
outcomes (Mitchell, et al., 1998).  
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 The system of interest in this study is the free clinic. The National Association of Free 
Clinics defines a free clinic as a volunteer-based, safety-net health care organization that 
provides a range of medical and/or behavioral health services to economically disadvantaged 
uninsured individuals. Free clinics serve mostly nonelderly adults, women, and minorities with 
low incomes(Darnell, 2010). There are over 1000 free clinics in the United States that provided 
care for 1.8 million individuals (Darnell, 2010). Free clinics focus on providing services less 
readily available to those without insurance such as medications and health education (Darnell).  
Intervention 
The intervention of interest in this study is the diabetes group medical visit. Mitchel et al, 
(1998) posit that clinical processes, such as delivering care thorough a DGMV, are direct and 
indirect interventions, however there is no single, direct connection linking interventions and 
outcomes. The model suggests a reciprocal direction of influence. Interventions affect and are 
affected by both system and patient characteristics in producing desired outcomes. The effect of 
an intervention is mediated by the patient and the system characteristics.  
Group Medical Visits 
A group medical visit is defined as any visit that attempts to provide group education 
while providing health care at the same time (Bray, 2005). This differs from group diabetes 
education where patients may receive group education but do not receive health care. Studies 
reviewed focused on DGMVs as an intervention and evaluated non-biophysical outcomes such 
as feasibility, cultural relevance, acceptability, efficacy, perceptions of care, self-care behaviors, 
trust in provider, cost, patient satisfaction, receipt of preventative services, quality of life, 
knowledge, locus of control, and self-management support.  
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A descriptive study was published by Keyserling et al. (2000) with the purpose of 
examining the feasibility of an intervention program  which included group medical visits 
designed to improve dietary physical activity, and self-care behaviors of older African American 
women with  diabetes. The sample consisted of 200 African American women with  diabetes. 
Focus groups were conducted to determine the cultural relevance and acceptability of the 
intervention. The authors report that the participants found group visits to be culturally relevant 
and acceptable. The effect of group visits on diet, physical activity, and self-care behaviors were 
not studied. The feasibility of group visits as an intervention is supported by a study conducted 
by Clancy, Cope, Magruder, Huang, Salter et al. (2003). The purpose of their experimental study 
was to evaluate the feasibility and acceptability of group visits to uninsured or inadequately 
insured patients with uncontrolled diabetes. Participants were predominantly African American 
(77.5%) and most of the participants had health-care insurance (73.1%). Clancy and colleagues 
(2003) found group visits to be feasible and acceptable to patients with uncontrolled  diabetes 
and fostered an improved sense of trust in their physician. More recently, a descriptive study was 
published by Barud, Marcy, Armor, Chonlahan, & Beach (2006). The authors evaluated the 
effectiveness of group medical visits for persons with diabetes in one family medicine center.  
The effectiveness of the group visits was evaluated by a 12-question patient satisfaction survey 
completed at the close of each group session. The survey was used to evaluate patient 
satisfaction with the experience at the center. Participants reported that group visits helped 
clinicians provide them with more efficient health-care and education than traditional care. Not 
only have group visits been found to provide more efficient care, they have also been shown to 
increase positive perceptions of health-care. Clancy, Yeager, Huang, & Magruder (2007) 
conducted a study to evaluate perceptions of care delivered through group visits to disadvantaged 
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patients with  diabetes. The design of the study was experimental. A total of 120 persons with 
diabetes were randomly assigned to receive their care in group visits or usual care for six 
months. After six months, patient satisfaction was measured by survey. The sample was 72 % 
female and 82% African American. The authors reported that patients assigned to group visits 
had generally more positive perceptions about their care in the areas of ongoing care, community 
orientation of care, and cultural competence of care than did those in usual care. However, one 
study did find that telephone management of diabetes may be better for some patients. 
Schillinger et al. (2007) attempted to describe the difference in self-management support systems 
in the dimensions of participation, representativeness and engagement between group visit 
participants and patients receiving individual support through telephone disease management. 
The study found that telephone disease management yielded higher engagement, especially 
among those with limited English proficiency and limited literacy. However, no statistical testing 
for differences in engagement between telephone disease management and group medical visits 
was performed.  In summary, this literature review supports that DGMVs have the potential to 
impact outcomes of care.  
Outcomes of Care 
An outcome is said to be a component of a patient’s clinical and functional status after an 
intervention has been applied (Barr, Schumacher, & Myers, 2001). The QHOM proposes that 
outcome measures should be the result of care structures and processes that integrate functional, 
social, psychological, physical, and physiologic aspects of people’s experience in health and 
illness (Mitchell et al., 1998). Studies reviewed evaluated common outcomes measured in 
diabetes populations outcomes of care such as HgA1C, weight,  blood pressure, fasting glucose, 
lipids, hypoglycemic episodes, anxiety, depression , end organ damage, and microalbumin 
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(Clancy, Brown, et al., 2003; Clancy, Yeager, Huang, & Magruder, 2007; Culhane-Pera et al., 
2005; Trento, et al., 2002; Trento et al., 2001; Wagner, et al., 2001). Additionally, some studies 
evaluated both biophysical outcomes as well as non-biophysical outcomes of care.  
Biophysical Outcomes of Care 
While HgA1C is commonly used to determine an improvement in glucose levels in 
persons with diabetes, multiple other outcomes measures can be used as indicators of improved 
care. Trento et al. (2002) published the results of a randomized controlled clinical trial to 
compare traditional individual diabetes care with a model in which routine follow-up was 
managed by interactive group visits. The study found that HgA1C increased in the usual care 
group but not in the group visit patients; those participating in group visits had a decrease in their 
BMI and an increase in HDL. In addition, the dosage of hypoglycemic agents decreased and 
retinopathy progressed less among the group care patients. Diastolic blood pressure and relative 
cardiovascular risk decreased from baseline in both the group visit and usual care patients. More 
biophysical outcomes of care were looked at by Kirsh et al. (2007). The purpose of the study by 
Kirsh and colleagues (2007) was to evaluate the impact of shared medical appointments on 
intermediate outcome measure of care for persons with diabetes focusing on those patients at 
highest cardiovascular risk. Chart reviews were conducted to collect data. The findings suggested 
that reductions in HgA1C, LDL, and systolic blood pressure were greater in the intervention 
group but the difference was not statistically significant. Another study which looked at only 
biophysical outcomes had similar findings. A quasi-experimental study published by Bray, 
Thompson, Wynn, Cummings, & Whetstone (2005) explored the efficacy of combining care 
management and interdisciplinary group visits for rural African American persons with diabetes 
mellitus. The vast majority of participants were African American (90%). Most patients had 
13 
 
health insurance through Medicare or Medicaid (83%). The intervention group had a significant 
decrease in HgA1C versus the control group compared over the same time period. No significant 
differences in mean weight or blood pressure between group visits and usual care were found.  
Biophysical Outcomes & Diabetes Group Medical Visits as an Intervention  
Biophysical outcomes do not always improve when using DGMVs as an intervention. 
Clancy, Cope, Magruder, Huang, & Wolfman (2003) published results of an experimental study 
to evaluate the effectiveness of a managed care approach to health care delivery, i.e. group visits, 
in the management of uninsured or inadequately insured patients with  diabetes. The participants 
were predominantly female (78.3%) and African American (77.5%). Most of the participants had 
health-care insurance (73.1%). The data collected were those charted as ADA standards of care: 
HgA1C and lipids over 6 months. Group visits were found to be more effective in promoting 
documentation of concordance with ADA standards of care than usual care. However despite the 
innovative delivery method, there were no significant differences seen in diabetes or lipid 
control. Five years later, Clancy, Huang, Okonofua, Yeager, & Magruder (2007) published a 
study with similar findings. The study evaluated the effect of group visits on documentation of 
clinical outcomes in concordance with 10 American Diabetes Association guidelines. The study 
was an experimental design with measures of  ADA standards of care at 6 and 12 month 
intervals.   The sample consisted of 186 patients with  diabetes, predominantly female (72 %) 
and African American (82%). Findings of the study at both measurement points were that 
HgA1C, blood pressure, and lipid levels did not differ significantly for patients attending group 
visits versus those receiving usual care. At 12 months, patients in group visits exhibited greater 
concordance with ADA process of care indicators and rates for cancer screening patients. The 
authors suggest that modification to the content and style of group visits may be necessary to 
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achieve improved clinical outcomes. Another study that measured biophysical and non-
biophysical outcomes of care had comparable results. Culhane-Pera et al. (2005) published the 
results of a study with the purpose of evaluating the influence of group visits on diabetes 
management in Hmong adults with  diabetes. The hypothesis of this study was that group visits 
would improve diabetes management. The authors reasoned that having a forum to discuss 
diabetes in a culturally familiar group setting would facilitate people’s acceptance of clinical 
services, medications, and lifestyle changes. The study findings were that participants received 
better services; however, biological parameters and mental health did not improve.  
 One study has shown positive effects of group visits for both biophysical and non-
biophysical outcomes of care. Wagner et al. (2001) published the results of a quasi-experimental 
study with 707  diabetes patients. The purpose of the study was to evaluate the impact of primary 
care group visits on the process and outcome of care for diabetic patients.   The findings of the 
study showed the intervention group had received significantly more recommended preventive 
procedures and patient education. There was a consistently positive association between the 
number of group visits attended and outcomes, such as patient satisfaction and HgA1C levels.  
Cost can also be decreased through implementation of group visits. Bray, Roupe et al. 
(2005) conducted a study to assess the feasibility and potential for cost effectiveness of 
restructuring care in rural fee-for-service practices for predominantly minority persons with 
diabetes. The majority of patients were African American (72%) and more than half of the 
patients were female (54%). The major findings of the study were an improvement in the 
percentage of patients achieving diabetes management goals. Additionally, there was 
improvement in the providers’ productivity and billable encounters. Increased monetary revenue 
can be accompanied by decreasing workloads of providers. Trento et al. (2001) conducted a 
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study to evaluate whether group visits in diabetes care are more effective than individual 
consultations in improving self-care and metabolic control. The hypothesis of their quasi-
experimental study was that individual visits could be merged with interactive group visits into a 
permanent therapeutic educational process, including interactive techniques, positive group 
dynamics and identification with other group members, without increasing the workloads of 
health care providers in outpatient diabetes care. The authors reported that participants in group 
consultations had stable HgA1C levels as compared to increased HgA1C levels in control group. 
The intervention group had lower cardiovascular risk scores, improved diabetes knowledge, 
better quality of life, improved health behavior scores and longer interaction with health-care 
providers, while the physicians spent less time seeing the group rather than completing 
individual appointments. 
 Diabetes group medical visits have been studied in various patient populations and 
numerous disciplines. Both qualitative and quantitative designs have been used to study this 
model for care. Qualitatively, researchers have studied diabetes group medical visits though 
interviews usually focusing on quality of life. Typically, in quantitative studies, health outcomes 
are measured to determine effectiveness of group visits. The outcomes measured vary from study 
to study. Frequently, studies that use group medical visits as an intervention, measure outcomes 
of adherence such as body mass index, weight, glycosylated hemoglobin, fasting blood glucose, 
blood creatinine, lipids, microalbuminuria, blood pressure, evidence of end organ damage, 
depression, anxiety, medication use, and foot care. Other studies evaluated process of care 
indicators such as prescribed ACE inhibitors, aspirin, cholesterol management, cholesterol 
treatment, measurement of glycosylated hemoglobin, measurement of microalbumin, 
Pneumovax administration, influenza vaccine administration, eye examination, and foot 
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examination (Chiu et al., 2009; Clancy, Brown, et al., 2003; Clancy, Yeager, et al., 2007; 
Culhane-Pera, et al., 2005; Guzek, Guzek, Murphy, Gallacher, & Lesneski, 2009; Trento, et al., 
2002; Trento, et al., 2001; Wagner, et al., 2001). Yet other studies have measured system 
characteristics such as the cost effectiveness, productivity and billable encounters of diabetes 
group medical visits (Bray et al., 2005; Clancy, Brown, et al., 2003; Clancy, Dismuke, 
Magruder, Simpson, & Bradford, 2008). Other than HgA1C, no two researchers found in this 
review, measured the same outcomes of care in persons with diabetes who received group 
medical visits or used the same measurement tools. The literature supported outcome measures 
that were used for the proposed study include body weight, body mass index, fasting blood 
glucose, HgA1c, serum creatinine, lipids, blood pressure and microalbumin.  
Patient Characteristics 
Mitchell and colleagues (1998) state that patient characteristics are factors that directly 
affect outcomes and include client health, demographics, and disease risk factors. Age, gender, 
ethnicity, marital status, duration of diabetes, education, distance from clinic, co-morbidities, and 
depression are all patient characteristics commonly measured in diabetes group medical visits 
(Barud, et al., 2006; Bray, Roupe, et al., 2005; Bray, Thompson, Wynn, Cummings, & 
Whetstone, 2005; Clancy, Brown, et al., 2003; Clancy, et al., 2008; Clancy, Yeager, et al., 2007; 
Culhane-Pera, et al., 2005; Keyserling, et al., 2000; Schillinger et al., 2007; Trento, et al., 2002). 
Examining patient characteristics may identify which patient populations for which DGMVs are 
most beneficial.  
Age 
Age of patients has been associated with self-management activities, thus affecting 
outcomes of care. The World Health Organization (2003) reports that in most studies of 
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adherence, age of the patient was associated with outcomes of care (Sabate, World Health, 
Project, & Global Adherence Interdisciplinary, 2003). Leventhal et. al, (2001) reported that 
compared to younger participants, persons with diabetes over the age of 25 reported exercising 
on fewer days per week, and spending less time in recreational physical activities. Older adults 
may also practice better self-management than younger adults (Leventhal H, 2001). Additionally, 
the fact that glucose intolerance increases with age has been apparent for over 30 years (Andres, 
1971).  
Ethnicity 
Other patient characteristics such as ethnicity can affect outcomes as well. The rate of 
diabetes is increasing fastest in ethnic minorities, including African Americans, Mexican 
Americans, and Native Americans (Promotion, Accessed September 20, 2010). Because of 
cultural differences, ethnicity is reported to be a risk factor for poorer quality in health care, 
disease management and disease control. Ethnic minority groups are at risk for poorer quality of 
life and increased disease complications when compared with non-ethnic counterparts living in 
the same country (Mc Manus & Savage). Mitchell and colleagues (1998) suggested that client 
characteristics, such as ethnicity have a meaningful, direct effect on behavioral and health status 
outcomes. It is believed that clients live in a social environment with cultural values and beliefs 
about health and healthcare (Mitchell, et al., 1998). These values and beliefs affect the patients’ 
desire to interact and ability to interact with a care delivery system (Holzemer, 1994).  
Comorbidities 
The majority of older adults have two or more chronic conditions and among patients 
with diabetes, 40% have at least three (Sabate, et al., 2003). Patients with a greater overall 
number of comorbidities place lower priority on diabetes and have worse diabetes self-
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management ability scores (Glasgow, Toobert, & Hampson, 1996). The type and severity of 
comorbid conditions can affect outcomes of care. Patients with severely symptomatic 
comorbidities and those with conditions they consider to be unrelated to diabetes may need 
additional support in making decisions about care priorities and self-management activities (Kerr 
et al., 2007).  
One co-morbidity that may affect outcomes of care in persons with diabetes is 
depression. The incidence of depression has been observed to be twice as high among persons 
with diabetes than in the general population (J. J. Prochaska, Nigg, Spring, Velicer, & 
Prochaska). Patients with depression are more likely to experience complications of diabetes, 
have worse glycemic control, and be less adherent to self-care behaviors than patients who are 
not depressed (J. O. Prochaska, 2008). 
Other Patient Characteristics 
Other patient characteristics such as gender, duration of diabetes, miles to clinic, and 
educational level also are suggested to affect outcomes of care. Gender has been associated with 
outcomes such that men with diabetes have been found to be more physically active than women 
with diabetes, but they also consume more calories, eat more inappropriate foods and have lower 
levels of adherence (Whitlock, Vogt, Hollis, & Lichtenstein, 1997). Duration of disease appears 
to have a negative relationship with adherence: the longer a patient has had diabetes, the less 
likely he or she is to be adherent to treatment (Glasgow, Davidson, Dobkin, Ockene, & Spring, 
2006). Longer driving distances from home to the site of primary care were associated with 
poorer glycemic control in older, rural subjects (Strauss, MacLean, Troy, & Littenberg, 2006). 
Educational level has been shown to be significant in disease control of diabetes patients. On the 
National Health and Nutrition Examination Survey from 1999 to 2006 those persons with 
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diabetes who are more educated have consistently shown an improved HgA1C, blood pressure 
and total cholesterol level than those who are less educated (McWilliams, Meara, Zaslavsky, & 
Ayanian, 2009). Education level and health literacy also appear to have an effect on participation 
in medical decision making and thus may impact outcomes of care (DeWalt, Boone, & Pignone, 
2007). Patient characteristics that will be examined in the proposed study are therefore, age, 
gender, ethnicity, marital status, duration of diabetes, education miles form clinic, comorbidity, 
and depression. 
Synthesis 
Group visits for persons with diabetes have been found to be feasible (Keyserling, et al., 
2000). This practice change has been implemented in a variety of clinical systems. Patients have 
reported that group visits are an acceptable form of health care, and minority populations find 
that group visits are culturally relevant (Keyserling, et al., 2000).  
Feasibility, cultural relevance, acceptability, trust in provider, cost, self-management 
support, perceptions of care, satisfaction, receipt of preventive services, insurance status, and 
efficacy have been studied while providing DGMVs as an intervention. The outcomes of care 
that have been studied with DGMVs are HgA1C, weight, blood pressure, fasting glucose, lipids, 
hypoglycemic episodes, anxiety, depression, end organ damage, microalbumin, self-care 
behaviors, patient quality of life, knowledge, ethnicity, and locus of control. Patient 
characteristics commonly studied in relation to DGMVs have been age, gender, ethnicity, marital 
status, duration of DM, education, miles from clinic, co-morbidities and depression.  
Research documented that persons with diabetes who participate in group visits as an 
intervention experience an increase in the following: satisfaction with care, interaction with 
providers, diabetes knowledge, education, quality of life and preventive procedures and 
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screenings (Trento, et al., 2001; Wagner, et al., 2001). Clinical outcomes associated with group 
visits have been documented to include: decreased or stable HgA1C, decreased cardiovascular 
risk, decreased or stable BMI, decreased in LDL, increased in HDL, decreased or stable blood 
pressure and slowed progression of retinopathy (Clancy, Cope, et al., 2003). Positive clinical 
outcomes have been achieved with an increase in provider trust and a decrease or more effective 
use of provider time (Clancy, Cope, et al., 2003). However, worsening of diabetes control is only 
found to have been prevented in studies where patients had peer support and consultation with a 
physical or other health care provider (Philis-Tsimikas et al., 2004; Trento, et al., 2001).   
 While these findings regarding group visits are promising, some major limitations in the 
evidence still exist. Random assignment to treatment was rare in the studies reviewed. Because 
most subjects volunteered to be involved in the treatment, selection bias may have occurred, as 
highly motivated patients are more likely to volunteer. The majority of the participants in each 
study were from ethnic minority groups and female. All but one study focused on participants in 
their 5
th
 and 6
th
 decades of life. Most of the participants had some type of health care insurance. 
While these studies add to the body of knowledge regarding group medical visits for persons 
with diabetes, lack of randomization and lack of heterogeneity limits generalizability of the 
findings.  
The purpose of this study was to analyze the relationship between attendance at Diabetes 
Group Medical Visits (DGMVs) and biophysical outcomes of care in uninsured persons with 
diabetes who are cared for in a free clinic. The conceptualization of the QHOM for the purposes 
of this study is shown in Figure 2. The system characteristic in this study was a free clinic for 
those who are uninsured in North Central West Virginia. This system characteristic remained 
constant for all subjects. The intervention will be Diabetes Group Medical Visits. The patient 
21 
 
characteristics studied were age, gender, ethnicity, marital status, duration of DM, education, 
miles from clinic, co-morbidities, and depression. The outcomes measured were body weight, 
BMI, fasting blood glucose, HgA1C, creatinine, lipids, blood pressure, and microalbumin. All 
outcomes were compared before and after group medical visits, as well as to a group of patients 
in the same system who received traditional care.   
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Figure 2: Conceptualization of QHOM for DGMVs 
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Figure 3: Deconstructed Model for Proposed Study 
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CHAPTER 3: METHODOLOGY 
The purpose of this study was to examine the relationship between attendance at Diabetes 
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with 
diabetes who receive care in a free clinic. Specifically the aims of this study were: 
1. To describe the characteristics of uninsured persons with diabetes who are cared for in a 
free clinic. 
2. To describe the biophysical outcomes of care in uninsured persons with diabetes who are 
cared for in a free clinic. 
3. To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and one year after attending DGMVs. 
4. To compare biophysical outcomes of care in uninsured persons with diabetes who receive 
usual care in a free clinic at baseline and after one year. 
5. To analyze the differences in biophysical outcomes in persons with diabetes who attend 
DGMVs versus those who receive usual care in a free clinic at base line and then again 
after one year.  
6. To analyze the differences in characteristics of uninsured persons with diabetes who are 
attendees of DGMVs verses those who receive usual care. 
7. To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured 
persons with diabetes who receive care in a free clinic after one year.  
 This chapter conceptually and operationally defines measures used to meet the study aims and 
describes study methods.  
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Variable Definitions 
Diabetes Group Medical Visits 
 Conceptual Definition 
The group medical visit model was developed in managed care to improve effectiveness 
of care of patients (Clancy, Huang, Okonofua, Yeager, & Magruder, 2007).  Mental health 
providers and behavioral therapists have long recognized the value of groups when seeking 
improved psychological and behavioral outcomes for people with chronic illnesses (Beck et al., 
1997).  Group interaction appears to provide emotional support while lessening feelings of 
isolation and stigmatism that are associated with some chronic illnesses (Weinger, 2003).  A 
group medical visit must include at least two patients, who are united in a health-related 
situation, and a medical provider (Barud, et al., 2006). Each patient must share similar 
experiences and be willing to participate in a group. All parties need to possess the ability to 
receive and respond to social interaction. Group participants must also possess specific 
knowledge derived from personal experience. All group medical visits include some degree of 
information, appraisal and emotional support (Dennis, 2003). Additionally, some form of health 
care provider is present.  In this, group visits differ from other forms of group interventions, such 
as support groups or diabetes education, which are generally led by peers and do not include one-
on-one consultations with a health care provider.  
Operational Definition  
In the free clinic where this study took place, the DGMV was an additional health care 
visit and is meant to supplement individual healthcare visits to improve patient outcomes. 
Diabetes Group medical visits included group education and interaction and elements of an 
individual patient visit, such as the collection of vital signs, history taking, physical exam, 
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medication adjustments, appropriate standardized referrals, and laboratory procedures related to 
diabetes care (Jaber, Braksmajer, & Trilling, 2006). The curriculum for this clinic’s DGMV, 
which was adapted from the American Diabetes Association’s standards of care 
(AmericanDiabetesAssociation, 2010) was developed by the Nurse Practitioner at the clinic in 
conjunction with a Pharmacist (PharmD) who is obtaining certification in diabetes education. 
The free clinic offered up to six DGMVs in which the patients were provided education about 
blood glucose monitoring, medication, nutrition, exercise, foot care, heart disease, complications 
including sick day care, and behavior changes. The patients were scheduled to attend the clinic 
up to once a month until they had received all of the education offered by the DGMVs. Because 
the classes were offered four times per month, the patients could schedule at their convenience. 
Hence, the participants in each group varied from class to class. Patients were referred to the 
DGMV by their primary care provider for additional care. Attendance at the DGMVs was 
voluntary.  Data related to the number of DGMVs were collected from the chart and was coded 
1,2,3,4,5 or 6 depending on the number of visits patients experienced. Data were also collected 
on which DGMVs the patient attended. The data were recorded as categorical for each of the 
following DGMV categories: blood glucose monitoring, medication, nutrition, exercise, foot 
care, heart disease, complications including sick day care, and behavior changes.  
Usual Care 
 Conceptual Definition 
 Usual care can be defined as the routine care received by those patients who did not 
participate in DGMVs. The American Diabetes Association (ADA) has built the foundation by 
which providers direct their medical treatment for diabetes management. Ten established 
guidelines backed by research findings have become the standard for diabetes medical 
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management. Recommendations for all persons with diabetes are to have annual retinal and foot 
exams, annual influenza vaccinations, and pneumococcal immunizations, and monitoring of 
blood pressure, urine microalbumin levels, lipid profiles, quarterly measurement of HgA1C, and 
cardiovascular risk factor assessment with treatment as indicated for all abnormal results. 
 Operational Definition 
Usual care for persons with diabetes in the free clinic where the study took place included 
collection of vital signs, history taking, physical exam, medication adjustments, appropriate 
referrals, laboratory procedures, and education provided by the health care provider related to 
general care. Usual care did not include education provided by a Pharm D or diabetes educator 
with a group of other diabetes patients at the time of the usual care visit. Data related to the 
number of care visits during the study period were collected from the chart as a continuous 
variable.  
Biophysical Outcomes of Care 
Conceptual Definition 
 An outcome is said to be a component of a patient’s clinical and functional status after an 
intervention has been applied (Barr, et al., 2001). Biophysics refers to the process of assigning an 
objective measurement to a bodily process. For the purposes of this study, a biophysical outcome 
of care was defined as the measurable result of care collected over a specific time frame. 
Common biophysical outcomes measured in diabetes populations are body weight, body mass 
index (BMI), glycosylated hemoglobin (HgA1C), fasting blood glucose (FBG), serum creatinine, 
serum lipids, urine microalbumin, and blood pressure (Clancy, Brown, et al., 2003; Clancy, 
Yeager, et al., 2007; Culhane-Pera, et al., 2005; Trento, et al., 2002; Trento, et al., 2001; Wagner, 
et al., 2001).  
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Operational Definition 
 This study collected the common biophysical outcomes measured in diabetes, body 
weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, urine microalbumin, 
and blood pressure.  
Body Weight 
 Body weight was obtained routinely and recorded in the chart at the beginning of each 
clinic visit. Weight was measured and recorded in pounds (lbs). The clinic used an upright 
mechanical medical scale with capacity to weigh patients up to 350 lbs. This study collected the 
first body weight available prior to May 2007 and the most recent body weight recorded on or 
before August 18, 2009. The weight of patients that weigh more than 350 lbs is reported in the 
chart as “350+.”  These data were recorded and analyzed as a continuous variable.  
Body Mass Index 
 Body mass index was calculated with the following formula: weight (lb) / [height (in)]
2
 x 
703. Height was collected via patient report and recorded in the chart upon initial visit. Weight 
was obtained routinely and recorded in the chart at the beginning of each clinic visit. This study 
collected the first body weight available prior to May 2007 and the most recent body weight 
recorded on or before August 18, 2009. BMI was calculated based on the initial patient reported 
height. These data were entered as a continuous variable.  
Glycosylated Hemoglobin 
 Glycosylated Hemoglobin levels were drawn as part of routine diabetes care. In this 
clinic the measurement of HgA1C was performed by two separate outside laboratories. One 
laboratory used the Dade Dimension technique, applying the turbidimetric inhibition 
immunoassay principle, where the total hemoglobin was based on a modification of the alkaline 
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hematin reaction (McMillan, 2009). The percentage of total hemoglobin that was glycated was 
calculated and reported as %HgA1C. The reference range is 4.8 to 6.0%. The other laboratory 
performed HgA1C testing using the BioRad Variant II system, which used ion exchange high-
performance liquid chromatography (HPLC) to determine percentage of glycated hemoglobin 
(Hinkle, 2009). The reference range is 4.4% to 6.8%. The American Diabetes Association (2010) 
recommends that laboratories use only Glycohemoglobin assay methods that have been approved 
by the National Glycohemoglobin Standardization Program. Both laboratories met these 
requirements and reported results in percentage of HgA1C. While the laboratories reported 
different reference ranges, both laboratories reported values in percentage of HgA1C.  Hence, the 
difference in laboratory testing procedures was not clinically significant and would not affect 
percentage values or clinical decision making. This study collected the first HgA1C available 
prior to May 2007, and the most recent HgA1C recorded on or before August 18, 2009. These 
data were recorded and analyzed as a continuous variable.  
Fasting Blood Glucose 
Fasting blood glucose measures blood glucose after a patient has not eaten for at least 8 
hours. Fasting blood glucose was self-reported by the patient and recorded in the clinic visit note. 
All patients measure fasting blood glucose with a glucometer provided for home use by the free 
clinic. The meter then displays the level in milligrams per deciliter. This study collected the first 
fasting glucose available prior to May 2007 and the most recent fasting blood glucose recorded 
on or before August 18, 2009. These data were recorded and analyzed as a continuous variable.  
Serum Creatinine 
A serum creatinine test measures the amount of creatinine in the blood. The test was done 
to evaluate kidney function. Creatinine levels were drawn as part of routine diabetes care. In this 
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clinic, the measurement of serum creatinine was performed by two separate outside laboratories. 
Both laboratories reported creatinine in milligrams per deciliter.  The reference range for both 
laboratories is 0.5 – 1.2 milligrams per deciliter. This study collected the first serum creatinine 
available prior to May 2007, and the most recent serum creatinine recorded on or before August 
18, 2009.  These data were recorded and analyzed as a continuous variable. 
Serum Lipid levels 
 Serum lipid levels are considered to be any major lipid in the circulation. Serum lipid 
levels were routinely collected and reported as total cholesterol, high density lipoproteins (HDL), 
low density lipoproteins (LDL), and triglycerides (TG). Serum lipid levels were drawn as part of 
routine diabetes care. In this clinic the measurement of serum lipid was performed by two 
separate outside laboratories. Both laboratories reported serum lipids in milligrams per deciliter. 
The normal reference range was equivalent in both laboratories. This study collected the first 
serum lipids available prior to May 2007, and the most recent serum lipids recorded on or before 
August 18, 2009.  These data were recorded and analyzed as four separate continuous variables. 
Urine Microalbumin 
Often urine microalbumin can be an earlier sign of potential kidney disease than serum 
creatinine. A urine microalbumin test measures the amount of albumin in the urine. The test was 
done to evaluate kidney function. Urine microalbumin was collected as part of routine diabetes 
care. In this clinic the measurement of urine microalbumin was performed by two separate 
outside laboratories. Both laboratories reported urine microalbumin in milligrams per deciliter. 
The normal reference range was equivalent in both laboratories. This study collected the first 
urine microalbumin available prior to May 2007, and the most recent urine microalbumin 
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recorded on or before August 18, 2009.  These data were recorded and analyzed as a continuous 
variable. 
Blood Pressure 
 Blood pressure was obtained routinely and recorded in the chart at the beginning of each 
clinic visit. Blood pressure was measured and recorded as systolic over diastolic millimeters of 
mercury. The clinic used an automated blood pressure cuff.   This study collected the first blood 
pressure available prior after May 2007, and the most recent blood pressure recorded on or 
before August 18, 2009. These data were recorded and analyzed as two separate continuous 
variables. 
Patient Characteristics 
 Patient characteristics collected were: age, gender, ethnicity, marital status, duration of 
diabetes, education level, distance in miles from residence to clinic, depression score, and co-
morbidities.  
Age 
 Age was collected from the chart from date of birth. Age was recorded at the age of the 
first visit within the time frame for the study. These data were recorded and analyzed as a 
continuous variable. 
Gender 
 Gender was collected from the chart, and recorded as a dichotomous variable, either male 
or female. 
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Ethnicity 
Ethnicity, recorded upon establishment of care at the clinic, was collected from the chart. 
Ethnicity was collected by patient self-report. Ethnicity was recorded in the following categories: 
White, African-American, Asian, Hispanic, Native American, and other. 
Marital status 
 Marital status was collected from the chart. Marital status is asked on the initial visit and 
was reassessed every year. Marital status was collected by patient self-report. The most recently 
recorded marital status was collected in the following categories: single, married, divorced, 
separated, widowed, significant other. 
Duration of diabetes 
 Duration of diabetes was collected by chart review using patient self report data. Subjects 
are asked to report the number of years that they have had diabetes during clinic visits. The 
duration of diabetes was recorded from the beginning of the study period. Duration of diabetes 
was recorded as a continuous variable. 
Educational Level 
 Education was collected by chart review. Education was recorded in the chart upon initial 
visit to the clinic. Education was recorded from the beginning of the study period in the 
following categories:  less than high school, graduated high school, some college, college 
graduate, master’s degree, doctorate, GED.  
Distance in miles from residence to clinic 
 Home address was recorded in the chart at the initial visit and is verified every visit. 
Miles from residence to the clinic was calculated with Yahoo Map Quest using the clinic address 
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and the patient address. Home address was not kept in any study data file. Miles from residence 
to clinic was analyzed as a continuous variable. 
Depression Score 
 Depression score was collected upon initial visit, using The Center for Epidemiologic 
Studies Depression Scale (CES-D) (Deeb-Sossa, 2003). The CES-D is a commonly used 
screening test for determining depression quotient. While the tool is not diagnostic of clinical 
depression, it has been used in the past as an indicator of depression. The CES-D was filled out 
by the patient and can be completed in less than five minutes at the first visit prior to receiving 
care at the free clinic. While the CES-D was to be filled out yearly, it is not commonly updated 
at the free clinic. Hence, it was not be measured as an outcome of care but rather as a patient 
characteristic. The CES-D measured depressive feelings and behaviors during the past week. 
Each question was scored using a range of zero to three points. A score of less than 15 indicated 
no or few depressive feelings and behaviors during the past week. A score of 15-21 indicated 
mild to moderate depression. A score of over 21 indicated the possibility of major depression. 
Depression score was collected and recorded as a categorical variable.  
Co-Morbidities 
 An ongoing list of active and prior medical conditions was kept on the medical chart.  For 
the purposes of this study, a co-morbidity was the diagnosis of all other chronic diseases an 
individual patient might have other than diabetes. The data were recorded as a continuous 
variable, reflecting the total number of co-morbidities the patient has and as a dichotomous 
variable as yes/no for each of the following co-morbidities: hypertension, kidney disease, 
hyperlipidemia, heart disease, depression, obesity, kidney disease, pain, eye disease, neuropathy, 
and frequent infections. In order to further investigate the impact of co-morbid conditions a 
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predictive index such as the Charlson co-morbidity scale was considered for use. .  However, due 
to the retrospective nature of this study, all data were not available to make use of the Charlson 
co-morbidity index.   
Sample 
 This retrospective study was conducted at a free clinic in West Virginia, using chart 
review of a convenience sample of patients who met the inclusion criteria. This study was 
approved by the Institutional Review Board of West Virginia University. The inclusion criteria 
are: 1) age > 18 years, 2) diagnosis of diabetes, 3) uninsured and received care at a free clinic 
during the study period. The only specific exclusion criteria would be an accidental charting of 
diabetes where no diabetes exists. Two independent groups were studied, those who attended 
DGMVs and those who did not attend DGMVs. To achieve a power of 0.8 considering a medium 
effect size to detect a difference in means between two independent groups, a sample of 51 
charts in each group was required (Calculated with G*Power 3). The significance level of  
p=0.05 was used. 
Data Collection 
A registry of all persons with diabetes who are patients was kept by the free clinic. The 
registry was reviewed by the research and clinic staff. All persons with diabetes who received 
care from May 2007, when DGMVs were started at the clinic, to August 18, 2009 were 
identified. The clinic underwent a change to electronic medical records throughout the year 
2008. Hence, some data were obtained from previous paper medical records and current 
electronic medical records. The medical records of all persons with diabetes within the study 
time frame were pulled from the medical record room by the staff at the clinic. If the data were 
entirely electronic, the electronic medical record was reviewed. No patient identifiers were 
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collected. No information was able to be linked back to the subject. The data were extracted from 
the paper medical record or electronic medical record by a medical assistant at the clinic. The 
medical assistant was educated by the investigator on data collection procedures. The medical 
assistant was provided with a training manual to keep in the clinic as a reference guide. The 
investigator was available via phone or e-mail for additional questions. Ten percent of the charts 
reviewed by the medical assistant over the first week of data collection were also reviewed by 
the investigator. An inter-rater reliability of 95% accuracy between the data collected by medical 
assistant and the data collected by the investigator was set and met. Identified charts were 
reviewed by the investigator or medical assistant in a private setting in the clinic. Biophysical 
outcomes of care were collected from the chart and recorded from two separate time periods. 
Biophysical outcomes for patients who did not participate in DGMVs were collected as reported 
in the chart during or after May 2007 and then again after one year. Biophysical outcomes of 
care were collected from the chart of patients who did participate in DGMVs prior to the initial 
DGMV and then again in one year. Data were entered into Microsoft Access for ease of use for 
the medical assistant collecting the data and then were converted into Statistical Package of 
Social Sciences (SPSS), version 18 for analysis of the data. Data was stored on a USB travel 
drive which was and continues to be password protected. The USB travel drive was and will 
continue to be kept in a locked office at the clinic or the locked office of the investigator when 
not in use. 
Analysis Plan 
Prior to analysis, the data were cleaned, looking for outliers or impossible values. This was 
accomplished by running frequencies and descriptive statistics and visually scanning for missing data 
and for patterns of missing data. Any variable item that had missing data such that it decreased 
power, or missing data with any identifiable pattern was not analyzed.  
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Aim 1: To describe the characteristics of uninsured persons with diabetes who are cared for in a 
free clinic. 
 To describe the characteristics of the study sample descriptive statistics was used. The 
categorical variables gender, ethnicity, marital status, education, and type of co-morbidities were 
analyzed using frequencies and frequency tables and were reported as percentages. The 
continuous variables age, duration of diabetes, number of co-morbidities, and miles from the 
clinic were analyzed using mean, median and standard deviation.  
Aim2: To describe the biophysical outcomes of care in uninsured persons with diabetes who are 
cared for in a free clinic. 
To describe the biophysical outcomes of the study sample, descriptive statistics were 
used. The continuous variables body weight, BMI, fasting blood glucose, HgA1C, creatinine, 
lipids, blood pressure, and microalbumin were analyzed using mean, median and standard 
deviation.  
Aim 3: To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and again one year after attending DGMVs. 
To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and again one year after attending DGMVs paired t-tests were used. Differences in 
means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, 
urine microalbumin, systolic blood pressure, and diastolic blood pressure before attendance and 
DGMVs were compared to means at one year after attending DGMVs. The level of measurement 
for these variables was at the interval/ratio level. The data were obtained from a representative 
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sample from the population. Tests for the assumptions necessary for the use of parametric 
statistics, such as normal distribution and homogeneity of variance, were performed. If after 
preliminary data analysis was performed, violation of assumptions was recognized, Wilcoxon 
Signed Rank test was used. If no assumptions were violated, a paired t-test was used. A value of 
p=0.05 was used to determine significance of the findings. 
Aim 4: To compare biophysical outcomes of care in uninsured persons with diabetes who 
receive usual care in a free clinic at baseline and after one year. 
To compare means of biophysical outcomes of care in uninsured persons with diabetes 
who receive care in a free clinic and again after one year, paired t-tests were used to look at the 
difference in means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, 
serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure. The level 
of measurement for these variables was at the interval/ratio level. The data were obtained from a 
representative sample from the population. Tests for the assumptions necessary for the use of 
parametric statistics, such as normal distribution of differences were performed. If after 
preliminary data analysis was performed, violation of assumptions was recognized, Wilcoxon 
Signed Rank test was used. If no assumptions were violated, a paired t-test was be used. A value 
of p=0.05 was used to determine significance of the findings. 
Aim 5:  To analyze the differences in biophysical outcomes in persons with diabetes who attend 
DGMVs versus those who receive usual care in a free clinic at base line and then again after one 
year.  
To analyze the differences in biophysical outcomes in persons with diabetes who attend 
DGMVs versus those who receive usual care in a free clinic after one year, independent t-tests 
were used to compare means for body weight, BMI, HgA1C, fasting blood glucose, serum 
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creatinine, serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood 
pressure. The level of measurement for these variables was at the interval/ratio level. The data 
were obtained from a representative sample from the population. The data were independent of 
one another. Tests for the assumptions necessary for the use of parametric statistics, such as 
normal distribution of each population and homogeneity of variance, were performed. If after 
preliminary data analysis was performed, violation of assumptions was recognized, Mann-
Whitney U test was used. If no assumptions were violated, an independent-samples t-test was 
used. A value of p=0.05 was used to determine significance of the findings. 
Aim 6: To analyze the differences in characteristics of uninsured persons with diabetes who are 
attendees of DGMVs versus those who receive usual care. 
To analyze the differences in characteristics of uninsured persons with diabetes who 
attend DGMVs versus those who receive usual care in a free clinic after one year group, means 
were calculated for each patient characteristic. Chi-square tests were used to look for differences 
in the categorical variables of gender, ethnicity, marital status, education, and type of co-
morbidities in patients who attended DGMV and patients who received usual care. Independent 
t-tests were used to compare means for age, duration of DM, miles from clinic, and number of 
co-morbidities. An assumption for use of the chi-square analysis is that the expected count in 
each category is greater than 5. If this assumption is violated, the categories of the categorical 
variables were collapsed until the assumption was met. A value of p=0.05 was used to determine 
significance of the findings. 
Aim 7: To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured 
persons with diabetes who receive care in a free clinic after one year.  
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To explore the relationship between the dosage of DGMVs and biophysical outcomes of 
care in uninsured persons with diabetes who receive care in a free clinic after one year, dose was 
collected a continuous variable on a scale from one to six. Correlations were performed with the 
outcomes of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, 
urine microalbumin, systolic blood pressure, and diastolic blood pressure at one year for those 
patients who attended DGMVs. Before performing a correlation analysis, a scatterplot was 
generated to check for violation of the assumptions of linearity. Each continuous variable was 
tested for normality. If assumptions of parametric testing were not violated Pearson r was used 
for analysis. If assumptions were violated Spearman rho was used for analysis. A value of 
p=0.05 was used to determine significance of the findings. 
Data Fidelity  
Due to the retrospective nature of the study, intervention fidelity is difficult to control. 
However, group visits at the clinic were conducted by one diabetes educator, one nurse 
practitioner and one medical assistant. The group intervention was held in the same education 
room in the clinic and the healthcare portion of the visit was delivered in one of  six very similar 
exam rooms. The educational content of all of the group visits were derived from one of six 
educational sessions developed for a standardized curriculum. The delivery format was 
consistent for each DGMV: instruction, questions, answers, goal setting and then individual 
patient health examinations.  
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CHAPTER 4: RESULTS 
The purpose of this study was to examine the relationship between attendance at Diabetes 
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with 
diabetes who receive care in a free clinic. This chapter discusses the results of the data analysis 
conducted after the retrospective chart review was completed. This chapter will be presented in 
the following manner: data collection, data treatment, sample, results, and summary.  
Data Collection 
 The following paragraph describes how the data for this study were obtained. The free 
clinic keeps a registry of all persons with diabetes. The registry was reviewed by the researcher 
and clinic staff. The charts of all persons with diabetes who received care from May 2007, when 
DGMVs were started at the clinic to August 18, 2009, were identified. The clinic underwent a 
change to electronic medical records throughout the year 2008. Hence, data were obtained from 
previous paper medical records and the current electronic medical records. No patient identifiers 
were collected. No information is able to be linked back to the patient. A medical assistant at the 
clinic extracted the data from the paper medical record and/or electronic medical record. The 
investigator educated the medical assistant about data collection procedures. Additionally, the 
medical assistant was provided with a data collection training manual, which was kept in the 
clinic as a reference guide. Ten percent of the charts reviewed by the medical assistant were also 
reviewed by the investigator. An inter-rater reliability of 95% accuracy between the data 
collected by medical assistant and the data collected by the investigator was set and met. 
Identified charts were reviewed by the investigator or medical assistant in a private setting in the 
clinic. Biophysical outcomes of care were collected from the chart and recorded for two separate 
time periods. Biophysical outcomes for patients who did not participate in DGMVs were 
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collected as reported in the chart during or after May 2007 and then again after one year. 
Biophysical outcomes of care were collected from the chart of patients who did participate in 
DGMVs prior to the initial DGMV and then again in one year.  
Sample 
This retrospective study was conducted with a convenience sample of patients at a free 
clinic in West Virginia. The data were obtained by reviewing the charts of all persons with 
diabetes who received care from May 2007 to August 18, 2009. Two independent groups were 
studied, those who attended DGMVs and those who received usual care. There were a total of 
111 patients who met the inclusion criteria. There were 53 participants who attended DGMVs 
and 58 participants who received usual care. This study was approved by the Institutional 
Review Board of West Virginia University.  
Data Treatment 
Data were entered into Microsoft Access and then were transferred into the Statistical 
Package of Social Sciences (SPSS), version 18 for analysis of the data. Data were stored on a 
USB travel drive which was password protected. The USB travel drive was and will continue to 
be kept in a locked office of the investigator when not in use. 
Prior to analysis, data were cleaned, looking for outliers or impossible values. Looking 
for outliers was accomplished by analyzing frequencies and descriptive statistics and visually 
scanning the data for impossible values, missing data and patterns of missing data. Duration of 
diabetes had 90.1% missing data. Hence, duration of diabetes was excluded from further 
analysis. The variable “depression score” had 27.9 percent (N=22) missing data for the total 
sample. The patients who attended group visits had depression scores missing from 11 cases 
(9.9%). The patients who received usual care had depression scores missing from 20 cases 
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(18%). For the purpose of this study, depression score was analyzed as a characteristic to 
describe the groups prior to intervention, not to compare the effectiveness of the intervention. 
The missing depression data will be noted as a limitation of the study. Microalbumin had 27% 
(N= 30) missing data at time one and 29.7% (N= 33) missing data at time two from the entire 
sample. Patients who attended DGMVs had no missing data in microalbumin at time one and 3 
cases (2.7%) were missing microalbumin data at time two. Patients who received usual care were 
missing microalbumin in 30 cases (27%) at time one and 30 cases (27%) at time two. The 
observed power for an independent t-test to compare microalbumin data in those who attended 
DGMVs versus usual care at time one and time two (N=78) is 0.616 using a significance level 
(p=0.05), and a medium effect size.  The observed power for microalbumin data may not be 
enough detect a significant difference in microalbumin in those who attended DGMVs versus 
usual care at time one and time two. The large amount of missing data for microalbumin for the 
patients who received usual care will be listed as a limitation of the study. Patients who received 
usual care had 13 cases (11.7 %) of lipid results missing at time two. The observed power for an 
independent t-test to compare lipid data in those who attended DGMVs versus usual care at time 
one and time two (N =98) is 0.825 using a significance level p=0.05, and a medium effect size. 
The observed power for an independent t-test is enough to show a significant difference, if one 
exists, in lipid data in those who attended DGMVs versus usual care at time two. No other 
variable had greater than 10% missing data.  
Statistical Assumptions 
The following paragraphs describe the statistical assumptions used for this study. To 
compare biophysical outcomes of care in persons with diabetes before attending DGMVs and 
again one year after attending DGMVs, paired t-tests were used.  Paired t-tests were also used to 
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compare means of biophysical outcomes of care in uninsured persons with diabetes who receive 
usual care in a free clinic and again after one year. Chi-square tests were used to look for 
differences in the categorical variables between patients who attended DGMVs and patients who 
received usual care. To examine dose of DGMVs, correlations were performed with biophysical 
outcomes at one year for those patients who attended DGMVs.  
Normal distribution and random samples are assumptions for both a paired t-test and an 
independent t-test. Q-Q plots were used to evaluate normal distribution. If Q-Q plots showed a 
normal distribution of the data, paired t-tests or independent t-tests were considered appropriate 
to analyze differences in biophysical outcomes. If Q-Q plots showed a non-normal distribution of 
the data, either the non-parametric alternative test was used or the Central Limit Theorem was 
applied. The non-parametric alternative test for a paired t-test is the Wilcoxon Signed Rank test. 
The non-parametric alternative test for an independent t-test is the Mann-Whitney U test. The 
Central Limit Theorem states that as the size of a sample of independent observations approaches 
infinity, the sampling distribution of the sample mean approaches a normal distribution. Hence, 
if n is large enough, typically greater than 30, the Central Limit Theorem can be applied 
(http://www.encyclopedia.com/doc/1G2-3045300301.html, 2008). Eta squared is the statistic 
used to measure the strength of relationship between two variables for a paired-samples t-test.  
Independent t-tests have additional assumptions. To use the independent t-test the data 
must be independent of each other. Another assumption of an independent t-test is that the 
population variances are equal. In this study, Levene’s test was used to evaluate the assumption 
of equal variances. If the Levene’s test p value was larger than .05, equal variances were 
assumed. If the Levene’s test p value was less than .05, the results were interpreted using the t 
value for the equal variances not assumed test.  
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An assumption for use of the chi-square analysis is that the expected count in each 
category is greater than 5. If this assumption was violated, the categories of the categorical 
variables were collapsed until the assumption was met. If the assumption of an expected count in 
each category of greater than 5 could not be met, the data were not analyzed.  
Before performing a correlation analysis, scatterplots were generated to check for 
violation of the assumptions of linearity. Each continuous variable was tested for normality. If 
assumptions of parametric testing were not violated, Pearson r was used for analysis. If 
assumptions were violated Spearman rho was used for analysis.  
Results 
 The results will be presented according to the aims of the study. The patient 
characteristics will be presented followed by the biophysical outcomes of the sample. Then the 
comparison of characteristics and biophysical outcomes between each group will be presented. 
Finally, the impact of dose of DGMVs on biophysical outcomes of care will be explored. Each 
aim is listed, followed by results and data charts of each result. A value of p=0.05 was used to 
determine significance of all findings. 
Aim 1: To describe the characteristics of uninsured persons with diabetes who are cared for in a 
free clinic. 
 To describe the characteristics of the study sample, descriptive statistics were used. The 
categorical variables gender, ethnicity, marital status, education, and type of co-morbidities were 
analyzed using frequencies. The majority of the patients were female, white, married, and had a 
high school education or less (See Table 1). Sixty-five percent of the patients were obese and the 
majority of the patients had hypertension (84%) and hyperlipidemia (64%). The continuous 
variables age, number of co-morbidities, and miles from the subject’s home to the clinic were 
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analyzed using mean and standard deviation. The mean age of the subjects in the study was 48 
years. The mean number of co-morbidities was 5 and the mean distance from the patient’s home 
to the clinic was 21 miles (See Table 2). 
  
46 
 
Table 1: Sample Characteristics Categorical Variables 
Demographic 
Variable N Percent 
Gender   
Male 29 26.1 
Female 82 73.9 
   
Ethnicity   
White 107 95.5 
African American 4 3.6 
Hispanic 1 0.9 
   
Marital Status   
Single 15 13.5 
Married 56 50.5 
Divorced 24 21.6 
Separated 7 6.3 
Widowed 9 8.1 
   
Education Level   
Less Than High School 27 24.3 
Graduated High School 44 39.6 
Some College 20 18.0 
College Graduate 1 .9 
GED 15 13.5 
   
Co-Morbidity   
HTN 84 75.7 
Kidney Disease 13 11.7 
Hyperlipidemia 64 57.7 
Heart Disease 18 16.2 
Depression 39 35.1 
Obesity 73 65.8 
Pain 16 14.4 
Neuropathy 9 8.1 
Frequent Infections 5 4.5 
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Table 2: Sample Characteristics Continuous Variables 
Demographic Mean Range  SD 
Age in years 48    21-64 10.8 
Total number of co-morbidities 5 0-11 1.3 
Distance from clinic in miles 21 0.7-124 20.4 
 
Aim 2: To describe the biophysical outcomes of care in uninsured persons with diabetes who are 
cared for in a free clinic. 
To describe the biophysical outcomes at time one of the study sample, descriptive 
statistics were used. The continuous variables body weight, BMI, fasting blood glucose, HgA1C, 
creatinine, lipids, blood pressure, and microalbumin were analyzed using mean and standard 
deviation (See Table 3). It is noted that there is a large standard deviation in urine microalbumin.  
Because these microalbumin numbers are known to be actual patient results and not aberrant data 
entry mistakes, the values were included in the data evaluation.  The mean body weight for 
subjects in this study was 226.5 pounds and the mean BMI of the subjects was 37.6.  The mean 
HgA1C in this population was 8%. The mean for urine microalbumin was 52.9 mg. The mean 
LDL cholesterol level of this sample was 104.6 mg/dl. The mean HDL cholesterol of this sample 
was 40.4mg/dl. The mean triglyceride level of this population was 198.6mg/dl.  
Table 3: Biophysical Outcomes of Care 
Biophysical 
Outcomes  N Mean Range SD 
Body Weight (lbs) 111 226.59 121-400 52.71 
BMI (kg/mg2) 111 37.60 21.5-58.7 28.48 
HgA1C (%) 110 8.09 5-13.6 1.94 
Blood Glucose (mg/dl) 111 183.94 51-568 89.55 
Creatinine (mmol/l)  111 0.93 .44-4.2 0.45 
Microalbumin (mg/mmol) 81 52.95 .20-1120.8 157.96 
Systolic (mmHg) 111 129.50 90-190 19.65 
Diastolic (mmHg) 111 80.41 59-121 13.15 
Total Cholesterol (mg/dl)  108 188.82 88-337 45.80 
HDL (mg/dl) 107 40.40 17-83 10.63 
LDL (mg/dl) 104 104.65 5-201 40.44 
Triglycerides (mg/dl) 103 198.67 36-1156 169.17 
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Aim 3: To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and again one year after attending DGMVs. 
To compare biophysical outcomes of care in persons with diabetes before attending 
DGMVs and again one year after attending DGMVs, paired t-tests were used. The sample in this 
study is not random. This retrospective study was conducted on a convenience sample of patients 
at a free clinic in West Virginia. However, paired t-tests are commonly used in retrospective 
studies. Q-Q plots were analyzed on the differences between time one and time two for the 
following biophysical outcomes: body weight, BMI, HgA1C, fasting blood glucose, serum 
creatinine, serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood 
pressure. The data did not meet the assumption of normality for the following biophysical 
outcomes: body weight, BMI, creatinine, microalbumin, and triglycerides (See Appendix A). 
However, since the sample size was large, the results of parametric testing are still valid due to 
the Central Limit Theorem. Hence paired-samples t-tests were used to evaluate the impact of 
DGMVs on patients’ biophysical outcomes of care.  
Means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum 
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure before 
attendance at DGMVs were compared to means at one year after attending DGMVs. There was a 
statistically significant decrease in systolic blood pressure from time one (M=132.32, SD=18.31) 
to time two (M=126.83, SD=18.31), t(52)=2.18, (p=0.03). The mean decrease in systolic blood 
pressure from time one to time two was 5.49 mm/Hg with a 95% confidence interval ranging 
from 0.443 to 10.539, a range of values for the estimated population parameter. The eta squared 
statistic (.08) indicated a moderate effect size.  No other significant impact on biophysical 
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outcomes of care in persons with diabetes before attending DGMVs and again after attending 
DGMVs was noted (See Table 4). 
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Table 4: Biophysical Outcomes of Care Before and After DGMVs 
Biophysical Outcome N Mean SD df t p 
Body Weight Time One (lbs) 53 232.11 
17.50 52.00 -1.77 0.08 
Body Weight Time Two (lbs) 53 236.38 
    
  
     
BMI Time One (kg/mg2) 53 38.21 
2.78 52.00 -0.095 0.37 
BMI Time Two (kg/mg2) 53 38.58 
    
  
     
HgA1C Time One (%) 53 8.65 
1.99 52.00 -0.16 0.87 
HgA1C Time Two (%) 53 8.69 
    
  
     
Blood Glucose Time One (mg/dl) 53 194.17 
99.14 52.00 -0.42 0.67 
Blood Glucose Time Two (mg/dl) 53 199.92 
    
       
Creatinine Time One (mg/mmol) 51 0.89 
0.27 50.00 -1.05 0.30 
Creatinine Time Two (mg/mmol) 51 0.93 
    
  
     
Microalbumin Time One (mg//mmol) 50 59.36 165.94 49.00 1.52 0.13 
Microalbumin Time Two (mg//mmol) 50 23.60 
    
  
     
Systolic Time One (mgHg) 53 132.32 
18.31 52.00 2.18 0.03 
Systolic Time Two (mgHg) 53 126.83 
    
  
     
Diastolic Time One (mgHg) 53 81.92 
12.38 52.00 1.22 0.23 
Diastolic Time Two (mgHg) 53 79.85 
    
  
     
Total Cholesterol Time One (mg/dl) 52 192.67 
48.53 51.00 0.45 0.65 
Total Cholesterol Time Two (mg/dl) 52 189.63 
    
  
     
HDL Time One (mg/dl) 52 40.38 
8.93 51.00 -0.95 0.35 
HDL Time Two (mg/dl) 52 41.56 
    
  
     
LDL Time One (mg/dl) 48 100.73 
44.91 47.00 0.95 0.35 
LDL Time Two (mg/dl) 48 94.58 
    
  
     
Triglycerides Time One (mg/dl) 49 236.31 
192.56 48.00 0.72 0.48 
Triglycerides Time Two (mg/dl) 49 216.63     
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Aim 4: To compare biophysical outcomes of care in uninsured persons with diabetes who receive 
usual care in a free clinic at baseline and after one year. 
To compare means of biophysical outcomes of care in uninsured persons with diabetes 
who receive usual care in a free clinic and again after one year paired t-tests were used. Again, 
the sample in this retrospective study was not random. However, paired t-tests are commonly 
used in retrospective studies. Q-Q plots were analyzed on the differences between time one and 
time two for the following biophysical outcomes: body weight, BMI, HgA1C, fasting blood 
glucose, serum creatinine, serum lipids, urine microalbumin, systolic blood pressure, and 
diastolic blood pressure. For those who receive usual care, the data do not meet the assumption 
of normality for the following biophysical outcomes: body weight, HgA1C, BMI, blood glucose, 
creatinine, microalbumin, diastolic blood pressure, LDL, and triglycerides (See Appendix B). 
However, due to the Central Limit Theorem, parametric testing is still valid for all biophysical 
outcomes except microalbumin. The Central Limit Theorem cannot be applied for the 
microalbumin outcome, since it contains less than 30 cases. Hence paired-samples t-tests were 
used to evaluate the impact of usual care on patients for all biophysical outcomes of care except 
microalbumin. Wilcoxon Signed Rank test was used to evaluate the impact of usual care on 
microalbumin. 
Means of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum 
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure in patients who 
receive usual care at baseline and again after one year were compared. There was no significant 
difference between biophysical outcomes of care from time one to time two noted (See Table 5). 
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Table 5: Biophysical Outcomes of Care for Usual Care Patients at Baseline and After One Year 
Biophysical Outcome N Mean SD df t p 
Body Weight Time One (lbs) 58 221.55 57.25 
57 0.21 .836 
Body Weight Time Two (lbs) 58 221.17 53.27 
   
       
BMI Time One (kg/mg2) 58 37.08 8.83 
57 0.33 .745 
BMI Time Two (kg/mg2) 58 36.98 8.10 
   
       
HgA1C Time One (%) 52 7.52 1.66 
51 0.13 .896 
HgA1C Time Two (%) 52 7.49 1.55 
   
       
Blood Glucose Time One (mg/dl) 58 174.59 86.82 
57 -0.04 .970 
Blood Glucose Time Two (mg/dl) 58 175.05 83.95 
   
       
Creatinine Time One (mg/mmol) 53 0.95 0.61 
52 -0.60 .548 
Creatinine Time Two (mg/mmol) 53 0.97 0.55 
   
       
Microalbumin Time One (mg//mmol) 19 64.33 140.36 
 -.558(z) .557 
Microalbumin Time Two (mg//mmol) 19 68.87 188.26 
   
       
Systolic Time One (mgHg) 58 126.93 19.56 
57 0.46 .647 
Systolic Time Two (mgHg) 58 125.88 13.76 
   
       
Diastolic Time One (mgHg) 58 79.02 12.71 
57 -0.89 .375 
Diastolic Time Two (mgHg) 58 80.64 11.82 
   
       
Total Cholesterol Time One (mg/dl) 45 182.02 39.89 
44 1.26 .216 
Total Cholesterol Time Two (mg/dl) 45 175.87 33.87 
   
       
HDL Time One (mg/dl) 45 40.89 10.55 
44 -0.94 .351 
HDL Time Two (mg/dl) 45 41.80 10.75 
   
       
LDL Time One (mg/dl) 42 105.50 32.42 
41 1.49 .145 
LDL Time Two (mg/dl) 42 97.86 30.75 
   
       
Triglycerides Time One (mg/dl) 42 171.33 125.86 
41 0.09 .929 
Triglycerides Time Two (mg/dl) 42 169.57 105.21   
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Aim 5: To analyze the differences in biophysical outcomes in persons with diabetes who attend 
DGMVs versus those who receive usual care in a free clinic at baseline and then again after one 
year.  
Independent t-tests were used to compare means for body weight, BMI, HgA1C, fasting 
blood glucose, serum creatinine, serum lipids, urine microalbumin, systolic blood pressure, and 
diastolic blood pressure between the usual care group and the DGMV group at baseline and then 
again after one year. Again, the sample in this retrospective study was not random. However, 
independent t-tests are commonly used in retrospective studies. Q-Q plots were analyzed to 
assess the distribution of each biophysical outcome for patients who attended DGMVs and for 
patients who received usual care separately at time one and at time two for the following 
biophysical outcomes: body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, 
serum lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure (See 
Appendices C & D). For those who attended DGMVs, the data does not meet the assumption of 
normality for the following biophysical outcomes at time one and time two: HgA1C, blood 
glucose, creatinine, microalbumin, total cholesterol, HDL, LDL, and triglycerides. For those who 
received usual care the data does not meet the assumption of normality for the following 
biophysical outcomes at time one and time two: HgA1C, blood glucose, creatinine, 
microalbumin, systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, LDL, 
and triglycerides. However, the results of the parametric test are still valid due to the Central 
Limit Therom for the following variables in both groups: HgA1C, blood glucose, creatinine, 
systolic blood pressure, diastolic blood pressure, total cholesterol, HDL, LDL, and triglycerides. 
The Central Limit Therom cannot be applied to compare the mean of microalbumin between 
groups at time one or at time two, because microalbumin contains less than 30 cases in the usual 
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care group at both time one and time two. Hence, Mann-Whitney U test was used for the 
microalbumin comparisons. The homogeneity of variances assumption was violated for the 
biophysical outcomes of HgA1C at time one, LDL at time one, HgA1C at time two, systolic 
blood pressure at time two, and triglycerides at time two. Hence, the t value for equal variances 
not assumed was used to interpret the results of the comparisons of HgA1C at time one, LDL at 
time one, HgA1C at time two, systolic blood pressure at time two, and triglycerides at time two.  
To determine if the patients who attended DGMVs had differing biophysical outcomes 
than the patients who received usual care prior to the DGMV intervention, means of body 
weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum lipids, systolic blood 
pressure, and diastolic blood pressure in patients who attended DGMVs and those who received 
usual care at time one were compared. Due to the large amount of missing urine microalbumin 
data, the median of urine microalbumin in patients who attended DGMVs and those who 
received usual care at time one was used for comparison between the two groups. The patients 
who attended DGMVs had a higher HgA1C at baseline (p=0.003). There were no other 
significant differences in biophysical outcomes of care noted between the DGMV group and the 
usual care group at baseline, indicating that the groups were essentially similar prior to 
intervention (See Table 6).  
To examine differences in biophysical outcomes one year after attending DGMVs or 
receiving usual care, means of body weight, BMI, HgA1C, fasting blood glucose, serum 
creatinine, serum lipids, systolic blood pressure, and diastolic blood pressure at time two were 
compared. Due to the large amount of missing urine microalbumin data, the medians of urine 
microalbumin in patients who attended DGMVs and those who received usual care at time two 
were compared. The patients who attended DGMVs continued to have a higher HgA1C after one 
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year (p=0.001). There were no other significant differences in biophysical outcomes of care 
noted between the DGMV group and the usual care group at one year (See Table 7).  
 Although not statistically significant, the biophysical outcomes did change in the sample 
(See Table 8). Body weight increased in the DGMV group and BMI increased in both groups 
from time one to time two. Blood glucose increased in both groups from time one to time two. 
Creatinine increased in the DGMV group from time one to time two. Microalbumin decreased in 
both groups from time one to time two. Systolic blood pressure decreased in both groups. 
Diastolic blood pressure decreased in the DGMV group and increased in the usual care group 
from time one to time two. Total cholesterol decreased in both groups and HDL increased in 
both groups from time one to time two. LDL decreased in both groups from time one to time 
two. Triglycerides decreased in the DGMV group and increased in the usual care group from 
time one to time two. The only difference between the two groups at baseline was that the 
patients who attended DGMVs had a statistically higer HgA1C. The patients who attended 
DGMVs continued to have a statistically significant higher HgA1C after one year.   While the 
groups were equivalent except for a higher HgA1C in the group of patients who attended 
DGMVs, there were no other significant differences in biophysical outcomes of care noted at 
baseline or after one year.  
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Table 6: Differences in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at Baseline 
Biophysical Outcome Mean SD df t p 
Body Weight (lbs)      
Group Visits 232.11 47.17 109 1.06 .294 
Usual care 221.55 57.25    
      
BMI (kg/mg2)      
Group Visits 38.21 40.09 109 1.23 .222 
Usual care 37.08 8.83    
      
HgA1C (%)      
Group Visits 8.65 2.09 108 3.02 .003 
Usual care 7.57 1.64    
      
Blood Glucose(mg/dl)      
Group Visits 194.17 92.18 109 1.15 .252 
Usual care 174.59 86.82    
      
Creatinine (mg/mmol)      
Group Visits 0.89 0.19 109 -0.87 .384 
Usual care 0.97 0.60    
      
Microalbumin (mg/mmol)      
Group Visits 3.2(Md)   -1.053(z) .292 
Usual care 6.8(Md)     
      
Systolic Blood Pressure (mgHg)      
Group Visits 132.32 19.54 109 1.45 .150 
Usual care 126.93 19.56    
      
Diastolic Blood Pressure (mgHg)      
Group Visits 81.92 13.58 109 1.17 .246 
Usual care 79.02 12.71    
      
Total Cholesterol (mg/dl)      
Group Visits 192.72 50.05 106 0.87 .388 
Usual care 185.07 41.41    
      
HDL (mg/dl)      
Group Visits 40.38 10.65 105 -0.02 .981 
Usual care 40.43 10.71    
      
LDL (mg/dl)      
Group Visits 100.42 45.22 102 -1.07 .288 
Usual care 108.88 34.96    
      
Triglycerides (mg/dl)      
Group Visits 227.83 202.32 101 1.79 .077 
Usual care 168.94 121.83       
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Table 7: Differences in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at One Year 
Biophysical Outcome Mean SD df t p 
Body Weight (lbs)      
Group Visits 236.38 52.69 109 1.51 .134 
Usual care 221.17 53.27    
      
BMI (kg/mg2)      
Group Visits 38.58 8.48 109 1.01 .313 
Usual care 36.98 8.10    
      
HgA1C (%)      
Group Visits 8.69 2.23 104 3.27 .001 
Usual care 7.48 1.54    
      
Blood Glucose(mg/dl)      
Group Visits 199.92 102.76 109 1.40 .164 
Usual care 175.05 83.95    
      
Creatinine (mg/mmol)      
Group Visits 0.93 0.28 102 -0.45 .653 
Usual care 0.97 0.55    
      
Microalbumin (mg/mmol)      
Group Visits 2.75(Md)  7 -1.683 .092 
Usual care 6.0(Md)     
      
Systolic Blood Pressure 
(mgHg)      
Group Visits 126.83 19.21 109 0.30 .763 
Usual care 125.88 13.76    
      
Diastolic Blood Pressure 
(mgHg)      
Group Visits 79.85 11.74 109 -0.35 .725 
Usual care 80.64 11.82    
      
Total Cholesterol (mg/dl)      
Group Visits 189.63 55.55 96 1.38 .172 
Usual care 176.63 33.89    
      
HDL (mg/dl)      
Group Visits 41.56 11.84 96 -0.14 .892 
Usual care 41.87 10.64    
      
LDL (mg/dl)      
Group Visits 95.41 38.16 90 -0.06 .955 
Usual care 95.84 33.15    
      
Triglycerides (mg/dl)      
Group Visits 216.30 151.48 91 1.61 .111 
Usual care 172.02 105.19       
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Table 8: Changes  in Biophysical Outcomes in Those Who Attend DGMVs versus Usual Care at Time Two 
Biophysical 
Outcome 
DGMVs Usual Care 
Body Weight (lbs) ▲ 
 
▬ 
 BMI (kg/mg2) ▲ 
 
▲ 
 HgA1C (%) ▬ 
 
▬ 
 Blood Glucose(mg/dl) ▲ 
 
▲ 
 Creatinine (mg/mmol) ▲ 
 
▬ 
 Microalbumin (mg/mmol) ▼ ▼ 
Systolic Blood Pressure 
(mgHg) 
▼ ▼ 
Diastolic Blood Pressure 
(mgHg) 
▼ ▲ 
 Total Cholesterol (mg/dl) ▼ ▲ 
 HDL (mg/dl) ▲ 
 
▲ 
 LDL (mg/dl) ▲ 
 
▲ 
 Triglycerides (mg/dl) ▼ ▲ 
 ▼= decrease      ▲=increase     ▬ = no change 
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Aim 6: To analyze the differences in characteristics of uninsured persons with diabetes who are 
attendees of DGMVs verses those who receive usual care. 
Chi-square tests were used to look for differences in the categorical variables of gender, 
ethnicity, marital status, education, and type of co-morbidities between patients who attended 
DGMVs and patients who received usual care. An assumption for use of the chi-square analysis 
is that the expected count in each category is greater than 5. Education level and ethnicity 
violated the assumptions by having an expected count of less than 5 observations in several 
categories. Education level had only one participant that graduated from college and no 
participants graduated or attended graduate school. Hence, the categories were collapsed. The 
participant who graduated from college was included in the “some college” category and the 
“master’s degree” and “doctoral degree” categories were removed. There were only five 
participants who reported being anything other than white. Hence, the categories were collapsed 
into white and non-white. The expected count was still less than 5 observations in ethnicity. 
Therefore, the characteristic of race/ethnicity was not analyzed. Marital status had an expected 
count of less than 5 observations in several categories. The marital status category was 
compressed into the categories married and not married. Any participant who was listed as 
single, divorced, separated, widowed was placed in the non-married category. Participants who 
were listed as married were placed in the married category.  
Independent t-tests were used to compare means for the continuous characteristics of age, 
miles from clinic, and number of co-morbidities between patients who attended DGMVs and 
patients who received usual care. Again, the sample in this retrospective study was not random. 
However, independent t-tests are commonly used in retrospective studies. Q-Q plots were used 
to assess distribution of age, miles from clinic, and number of co-morbidities for patients who 
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attended DGMVs and for patients who received usual care separately (See Appendices E & F). 
The data do not meet the assumption of normality for those who attended DGMVs or patients 
who received usual care. However, the results of the parametric test are still valid due to the 
Central Limit Theorem.  
The Chi-square test for independence indicated the patients who participated in DGMVs 
differed from the usual care group prior to the intervention by reporting significantly higher rates 
of the presence of depression, obesity and pain (See table 9). Independent t-tests showed no 
difference between the means for the continuous characteristics of age, miles from clinic, and 
number of co-morbidities between patients who attended DGMVs and patients who received 
usual care (See table 10). There were no other significant differences in characteristics at the 
beginning of the study between those who attended DGMVs and those who received usual care. 
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Table 9: Differences in Characteristics of DGMVs versus Usual Care Using X2 
Characteristic N % X2 Sig 
Gender 
 DGMV 
  Male 14 26.4 0.004 0.947 
  Female 39 73.6   
 Usual Care 
  Male 15 25.9   
  Female 43 74.1   
Marital Status 
 DGMV 
  Not Married 29 54.7 1.083 0.298 
  Married 24 45.3   
 Usual Care 
  Not Married 26 44.8   
  Married 32 55.2   
Education 
 DGMV 
  Less than High School 13 24.5 0.122 0.989 
  Graduated High School 22 41.5   
  Some College 10 18.9   
  GED 8 15.1   
 Usual Care 
  Less than High School 15 25.9   
  Graduated High School 23 39.7   
  Some College 12 20.7   
  GED 8 13.8   
HTN 
 DGMV 
  Has HTN 40 75.5 0.002 0.962 
  No HTN 13 24.5   
 Usual Care 
  Has HTN 44 75.9   
  No HTN 14 24.1   
Kidney Disease 
 DGMV 
  Has Kidney Disease 8 15.1 1.122 0.289 
  No Kidney Disease 45 84.9   
 Usual Care 
  Has Kidney Disease 5 8.6   
  No Kidney Disease 53 91.4   
Hyperlipidemia 
 DGMV 
  Has Hyperlipidemia 28 52.8 0.968 0.325 
  No Hyperlipidemia 25 47.2   
 Usual Care 
  Has Hyperlipidemia 36 62.1   
  No Hyperlipidemia 22 37.9   
Heart Disease 
 DGMV 
  Has Heart Disease 9 17 0.044 0.834 
  No Heart Disease 44 83   
 Usual Care 
  Has Heart Disease 9 15.5   
  No Heart Disease 49 84.5   
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Depression 
 DGMV 
  Has Depression 24 45.3 4.583 0.032 
  No Depression 29 54.7   
 Usual Care 
  Has Depression 15 25.9   
  No Depression 43 74.1   
Obesity 
 DGMV 
  Has Obesity 41 77.4 6.055 0.014 
  No Obesity 12 22.6   
 Usual Care 
  Has Obesity 32 55.2   
  No Obesity 26 44.8   
Pain 
 DGMV 
  Has Pain 12 22.6 5.565 0.018 
  No Pain 41 77.4   
 Usual Care 
  Has Pain 4 6.9   
  No Pain 54 93.1   
Neuropathy 
 DGMV 
  Has Neuropathy 6 11.3 1.405 0.236 
  No Neuropathy 47 88.7   
 Usual Care 
  Has Neuropathy 3 5.2   
  No Neuropathy 55 94.8   
Frequent Infections 
 DGMV 
  Has Frequent Infections 3 5.7 0.315 0.575 
  No Frequent Infections 50 94.3   
 Usual Care 
  Has Frequent Infections 2 3.4   
    No Frequent Infections 56 96.6     
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Table 10: Differences in Characteristics of DGMVs verses Usual Care Using Independent t-tests 
Characteristic Mean SD t p 
Age     
     DGMV 47 10.82 1.13 0.261 
     Usual Care 49 10.84   
     
Number of Co-Morbidities     
     DGMV 4.7 2.16 -1.31 0.193 
     Usual Care 4.2 2.11   
     
Distance from Clinic     
     DGMV 20.7 19.72 0.25 0.803 
     Usual Care 21.7 21.08     
 
Aim 7: To explore the impact of dose of DGMVs on biophysical outcomes of care in uninsured 
persons with diabetes who receive care in a free clinic after one year.  
To explore the relationship between the dosage of DGMVs and biophysical outcomes of 
care in uninsured persons with diabetes who receive care in a free clinic after one year, dose was 
collected as a continuous variable on a scale from one to six. Correlations were performed with 
the outcomes of body weight, BMI, HgA1C, fasting blood glucose, serum creatinine, serum 
lipids, urine microalbumin, systolic blood pressure, and diastolic blood pressure at one year for 
those patients who attended DGMVs. Before performing a correlation analysis, scatterplots were 
generated to check for violation of the assumptions of linearity. The scatterplots were visually 
scanned for outliers. When correlations were performed, no significant correlations were found 
between number of DGMVs attended and biophysical outcomes of care (See table 11). However, 
after analyzing frequencies, it is noted that only 18 individuals attended 3 or more DGMVs. 
Seventeen participants attended one visit and 18 participants attended two visits. The data were 
then collapsed into participants who attended 3 or more group visits and those who attended less 
than three visits. Because HgA1C is so commonly used to determine an improvement in glucose 
levels, HgA1C was also collapsed into goal met or goal not met. The American Diabetes 
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Association sets the goal for HgA1C at less than 7%. The continuous biophysical outcome of 
HgA1C was dichotomized using 7% as a threshold to create a new variable, those who were 
above 7% and 7% and below. A Chi-square test was used to analyze the differences between 
participants who attended 3 or more group visits and those who attended less than three visits 
and HgA1C goal met or not met. There were no significant differences between the HgA1C met 
or not met outcome of patients who attended three or more DGMVs and those who attended less 
than three DGMVs (See Table 12).  
Table 11: Correlation between Dose of DGMVs and Biophysical Outcomes 
  Body 
Weight 
Time 
Two 
BMI 
Time 
Two 
HgA1C 
Time Two 
Blood 
Glucose 
Time 
Two 
Creatinine 
Time Two 
Microalbumin 
Time Two 
Pearson 
Correlation 
.162 .101 -.041 -.014 -.017 -.161 
Sig.  .248 .473 .769 .918 .906 .263 
N 53 53 53 53 51 50 
       
  
Systolic 
Time 
Two 
Diastolic 
Time 
Two 
Total 
Cholesterol 
Time Two 
HDL 
Time 
Two 
LDL Time 
Two 
Triglycerides 
Time Two 
Pearson 
Correlation 
.150 -.086 -.156 -.158 .108 -.133 
Sig.  .284 .540 .269 .263 .459 .357 
N 53 53 52 52 49 50 
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Table 12: X2 for Dose of DGMVs & HgA1C Goal 
  N % X2 Sig 
2 or less DGMVs     
HgA1C at goal  10 28.6 0.518 0.323 
HgA1C above goal 25 71.4 
3 or more DGMVs   
HgA1C at goal  7 38.9 
HgA1C above goal 11 61.1 
 
Summary 
 This retrospective study was conducted with a convenience sample of patients at a free 
clinic in West Virginia. The majority of uninsured persons with diabetes who are cared for in this 
free clinic are female, white, married, with a high school education or less. There was a 
statistically significant decrease in systolic blood pressure from time one to time two in patients 
who attended DGMVs. No other significant impact on biophysical outcomes of care in persons 
with diabetes after attending DGMVs was noted. There was no significant impact on biophysical 
outcomes of care in patients who received usual care from time one to time two noted. The 
patients who attended DGMVs had a higher HgA1C at baseline than those who received usual 
care. The patients who attended DGMVs continued to have a higher HgA1C after one year than 
those patients who received usual care. Dose of DGMVs did not impact biophysical outcomes of 
care in uninsured persons with diabetes who received care in a free clinic. 
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CHAPTER 5: SUMMARY, DISCUSSION, AND IMPLICATIONS 
The purpose of this study was to examine the relationship between attendance at Diabetes 
Group Medical Visits (DGMV) and biophysical outcomes of care in uninsured persons with 
diabetes who receive care in a free clinic. The aims of the study were to describe the 
characteristics of uninsured persons with diabetes cared for in a free clinic, describe the 
biophysical outcomes of care, explore the differences in biophysical outcomes of care before and 
after attending DGMVs versus receiving usual care, and explore the impact of dose of DGMVs 
on biophysical outcomes of care. The subjects included in this study were in poor health. 
DGMVs had very little impact on biophysical outcomes of care in this study. This chapter 
interprets the results of the data analysis guided by the major concepts of the Quality Health 
Outcomes Model (QHOM), presents a discussion of the findings as compared to current 
literature, presents the limitations of the study, and suggests implications for future practice and 
research. 
Theoretical Framework 
The theoretical framework used to guide this study was the QHOM. The four major 
concepts included in this model are: system, interventions, patients, and outcomes. The QHOM 
posits that system characteristics are the mediators of patient characteristics and interventions in 
producing patient outcomes (Mitchell, et al., 1998). The QHOM proposes that outcome measures 
should be the result of care interventions that integrate functional, social, psychological, 
physical, and physiologic aspects of people’s experience in health and illness (Mitchell et al., 
1998).The QHOM further postulates that interventions affect and are affected by both the system 
and patient characteristics in producing desired outcomes (Mitchell, et al., 1997). Additionally, 
according to the QHOM, patient characteristics can affect outcomes of care.  
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The design of this study was guided by major concepts of the QHOM. The system in this 
study was a free clinic in North Central West Virginia, the intervention was DGMVs, the 
patients were low income uninsured adults, and the outcomes were biophysical measures. The 
environment of the clinic and the pre-existing qualifications necessary to become a patient at the 
free clinic affected the characteristics of the sample. Consequently, patient characteristics such as 
suboptimal physical condition, multiple co-morbid conditions, less education, younger age, 
longer driving distances to obtain care, Appalachian culture and lack of health care insurance 
influenced participation in the intervention and outcomes. Despite the intervention, the outcomes 
of care were essentially unchanged in subjects in this study, likely due to complex characteristics 
of persons who attended the free clinic. While the outcomes of the patients in this study were not 
positively impacted by the intervention, the framework of the QHOM was supported. The 
following paragraphs will show the relationships between patient characteristics, intervention 
and outcomes.  
Findings 
Patient Characteristics 
 The characteristics of uninsured adult patients who are cared for in a free clinic are not 
well documented in the literature. Hence, the first aim of this study was to describe the 
characteristics of uninsured persons with diabetes who are cared for in a free clinic. This study 
described age, gender, ethnicity, marital status, duration of DM, education, miles from clinic, co-
morbidities, and depression in this population. Participants had a mean of 5 co-morbid conditions 
other than diabetes. The majority of the patients were female, white, had a high-school education 
or less, and were age 50 or younger. The subjects being cared for in this free clinic drove long 
distances to receive care. 
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Number of co-morbid conditions has been documented to affect outcomes of care. 
Patients with a greater overall number of co-morbidities place lower priority on diabetes and 
have worse diabetes self-management ability scores (Glasgow, et al., 1996). Self-management of 
diabetes, such as checking glucose levels, taking medications, and adhering to dietary and 
activity recommendations is necessary to maintain optimal biophysical outcomes of care 
(American Diabetes Association, 2010).  
Gender has been documented to affect outcomes such as rates of obesity, amount of 
physical activity, and adherence. Females have a greater prevalence of obesity compared to 
males (Ferraro et al., 1992). Obesity causes insulin resistance which contributes to decreased 
effectiveness in lowering blood glucose. The resulting increase in blood glucose may raise levels 
outside the normal range and cause adverse health effects (McPhee, 2011). Men with diabetes 
have been found to be more physically active than women with diabetes (Carpenter, 1998) which 
may significantly lower cardiovascular risks and overall mortality (Church et al., 2004). Further, 
women have been found to consume more calories, make poor food choices and have lower 
levels of adherence than men (Whitlock, et al., 1997).  
Nearly all participants in this study were white. In order to receive care at this free clinic, 
subjects must have resided in West Virginia. West Virginia is in the only state that is entirely in 
Appalachia (AppalachianRegionalCommission, Retrieved 2011-06-04). Although this study did 
not collect data on culture, all of the participants of this study live in West Virginia. According to 
the 2000 United States Census, 74.2 percent of people residing in West Virginia are native to 
West Virginia (U.S.CensusBureau, 2000). Hence, it is the assumption of the researcher that the 
subjects of this study are members of Appalachian culture, and therefore subscribe to some of the 
social norms of the culture. These norms and beliefs affect the patients’ desire to interact with a 
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care delivery system (Holzemer, 1994). People from Appalachian culture possess core values 
such as individualism, self-reliance, and fatalism (Smith & Tessaro, 2005). These core values 
may affect a patient’s willingness to share personal information with outsiders. An outsider can 
be any person that is not familiar to the patient such as other patients and health care providers 
participating in group visits. In order for DGMVs to affect outcomes of care, each patient must 
share similar experiences and be willing to participate in a group (Barud, et al., 2006).  
Education level also appears to have an effect on participation in medical decision 
making and thus may impact outcomes of care (DeWalt, et al., 2007). Over one third of subjects 
in this study did not graduate high school. Educational level has been shown to be significant in 
disease control of persons with diabetes. On the National Health and Nutrition Examination 
Survey (NHANES) from 1999 to 2006, those persons with diabetes who had a high school 
education or greater had consistently shown improved outcomes such as decreased HgA1C, 
decreased blood pressure and decreased total cholesterol levels than those who were less 
educated (McWilliams, et al., 2009).  
The age of all subjects in this study is less than 65 and the majority of the subjects were 
age 50 and younger. Younger adult patients, less than 60 years old, are significantly less likely to 
attend education programs and multiple healthcare visits than older adult patients (Abdulwadud 
et al., 1997). Additionally, the largest reductions in HgA1C have been documented in patients 
who attend more healthcare visits (Brown et al., 2005). Consequently, lack of attendance to 
multiple healthcare visits and education programs by younger populations may contribute to 
decreased effectiveness of interventions.  
 Longer driving distances from home to the site of primary care have been associated with 
poorer outcomes in rural subjects (Strauss, et al., 2006). The majority of subjects in this study 
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live greater than twenty miles from the clinic making both traveling time to clinic and 
transportation difficult. Living far away from primary health care centers, particularly in West 
Virginia presents multiple barriers to care. These barriers include inability to quickly access care 
due to distance, lack of an interstate transportation system, lack of public transportation systems, 
and cost of transportation (Arcury, Preisser, Gesler, & Powers, 2005). These barriers affect a 
person's ability and willingness to obtain needed care (Arcury et al., 2005).  
Biophysical Outcomes Prior to Intervention 
The biophysical outcomes of patients who are cared for in a free clinic are not well 
documented in the literature. The second aim of this study was to describe the biophysical 
outcomes of care in uninsured persons with diabetes who are cared for in a free clinic. The 
outcomes examined in this study were body weight, BMI, fasting blood glucose, HgA1C, 
creatinine, lipids, blood pressure, and microalbumin. An outcome is said to be a component of a 
patient’s clinical and functional status after an intervention has been applied (Barr, et al., 2001). 
The biophysical outcomes of care of uninsured persons with diabetes who are cared for in this 
free clinic indicate suboptimal control of multiple co-morbid conditions.  
The mean BMI was in the severe obesity category for this sample of patients (Sturm, 
2007). Only 5% of this sample of patients had a BMI indicating normal body weight. The 
remaining 95% of this sample of patients were in the overweight to morbid obesity categories. 
According to the Standards of Medical Care released by the American Diabetes Association, 
weight loss has been shown to reduce insulin resistance. Insulin resistance leads to higher levels 
of blood glucose. The resulting increase in blood glucose can cause adverse health effects 
(McPhee, 2011). 
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The mean HgA1C in this population was 8.09 percent. Having a HgA1C above 8 percent 
means that the average daily blood glucose of this sample of persons with diabetes is above 
200mg/dl indicating significant chronic hyperglycemia (AmericanDiabetesAssociation, 2010). 
Current recommendations are set at achieving and maintaining a HgA1C of less than 7% for 
most patients (Nathan et al., 2009). More than 60% of the patients in this sample have HgA1C 
levels higher than recommended treatment goals. The American Diabetes Association suggests 
lowering HgA1C to below or around 7% in order to reduce microvascular and neuropathic 
complications of diabetes which contribute to blindness, chronic kidney disease, and lower limb 
amputations. 
While creatinine levels were normal in this sample, urine microalbumin was elevated. 
Maintaining normal creatinine levels and urine microalbumin reduce the risk of macrovascular 
disease. Persistent elevated urine microalbumin has been shown to be the earliest indication of 
diabetic nephropathy in diabetes patients (Garg JP, 2002). The level of microalbumin in this 
sample was in the range that indicates diabetic nephropathy. Microalbuminuria and nephropathy 
are also a well-established markers of increased coronary vascular disease risk (Garg JP, 2002).  
The lipid levels of this sample indicated dyslipidemia. According to the American 
Diabetes Association, patients with  diabetes have an increased prevalence of lipid abnormalities, 
which contributes to their high risk of coronary vascular disease. According to the American 
Diabetes Association, low levels of HDL cholesterol associated with elevated LDL and 
triglyceride levels, which are seen in this population, are the most prevalent pattern of 
dyslipidemia in persons with  diabetes. Elevating HDL and lowering LDL and triglyceride levels 
are crucial to preventing stroke, myocardial infarction, and other vascular complications 
(AmericanDiabetesAssociation, 2010).  
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Usual Care Group Outcomes 
 The forth aim of this study was to compare biophysical outcomes of care in patients who 
received usual care at baseline and again after one year. There were no significant differences 
between biophysical outcomes of care from time one to time two noted in those who received 
usual care. The subjects in this group were severely obese, with elevated HgA1C levels, 
nephropathy, and dyslipidemia at baseline and continued to be in sub-optimal physical condition 
after one year of usual care.  
 The majority of patients who received usual care in this free clinic had five or more 
visits to the clinic in the course of one year. Persons with diabetes who are treated with insulin 
should be seen by their healthcare provider at least every three to four months. Those who are 
treated with oral medications or who are managing diabetes through diet should be seen at least 
every four to six months (AmericanDiabetesAssociation, 2010). Hence, the subjects in this study 
who received usual care attended the clinic and received care at least as often as recommended 
by the ADA, if not more frequently. However, attending the clinic and receiving usual care did 
not affect outcomes of care in this sample of patients. These findings are similar to previous 
findings related to usual diabetes care. Despite advancing treatment options and providing 
ongoing diabetes care, biophysical outcomes of diabetes care continue to be less than optimal 
(SERVICES, et al., 2008).  
DGMV Intervention Group Outcomes 
 There were differences in the biophysical outcomes found in the sample of patients who 
attended DGMVs. Previous to the intervention, HgA1C was elevated in the patients who 
attended DGMVs and remained elevated after one year. Maintaining high HgA1C levels 
increases the risk of long-term complications of diabetes. Mean systolic blood pressure 
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decreased to acceptable levels based on clinical guidelines (AmericanDiabetesAssociation, 2002) 
in the patients who attended DGMVs after one year. People with both diabetes and hypertension 
have approximately twice the risk of cardiovascular disease than patients who have hypertension 
alone. Hence, reducing and maintaining blood pressure can decrease cardiovascular risk. 
However, there were no other significant differences in biophysical outcomes of care in the 
patients who participated in DGMVs after one year of care.  
The biophysical outcomes reported in other literature related to DGMVs showed that 
participants started nearer to treatment goals prior to intervention than the sample of patients in 
this study (Chiu, et al., 2009; Clancy, Brown, et al., 2003; Clancy, Yeager, et al., 2007; Culhane-
Pera, et al., 2005; Guzek, et al., 2009; Trento, et al., 2002; Trento, et al., 2001; Wagner, et al., 
2001). Most studies reviewed related to DGMVs reported HgA1C levels from 6.9-7.6 % 
(Keyserling et al., 2002; Wagner, 1998; Wagner, et al., 2001). Nearly 70% of the sample of 
patients who attended DGMVs had HgA1C levels above treatment goals at time one. 
Additionally, greater than 62% of the sample of patients who attended DGMVs had HgA1C 
levels above what has been previously seen in the literature. However, while HgA1c values are 
reported in most of the DGMV literature, other biophysical outcomes of care are inconsistently 
studied, making comparisons difficult. Suboptimal biophysical outcomes and complex patient 
characteristics of this sample make implementing interventions complex and perhaps less 
effective than in other populations.  
Another aim of this study was to explore the impact of dose of DGMVs on biophysical 
outcomes of care. Participants were able to attend up to six DGMVs in which they would be 
provided education about blood glucose monitoring, medication, nutrition, exercise, foot care, 
heart disease, complications including sick day care, and behavior changes. In addition to their 
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regular clinic visits, the patients can attend the clinic monthly until they have received all of the 
education offered by DGMVs. There was no significant relationship found between number of 
DGMVs attended and biophysical outcomes of care in this study. However, it is important to 
note that the majority of patients attended two or less DGMVs in one year. Previous studies 
reviewed related to DGMVs suggest that improved interventions are seen in those patients who 
attend DGMVs more frequently (Beck, et al., 1997; Trento, et al., 2002; Trento, et al., 2001). 
Other studies that reported improvement in measured biophysical outcomes related to 
participation in DGMVs measured outcomes after at least 2 years of care (Clancy, Huang, et al., 
2007; Trento, et al., 2002). Hence, the lack of improvement in biophysical outcomes of care in 
this sample of patients who attended DGMVs may be due to low attendance rates or less time 
between intervention and outcome measurement than in previous studies.  
Comparison of Usual Care and DGMV Intervention group outcomes 
 There were differences in patient characteristics in the sample of patients who attended 
DGMVs versus those who received usual care. Similar to the usual care group, the DGMV group 
had elevated HgA1C levels, nephropathy, and dyslipidemia. However, patients who participated 
in DGMVs had higher depression scores, were more obese and reported to have pain more 
frequently than patients who received usual care in this study. Patients with depression are more 
likely to experience complications of diabetes, have worse glycemic control, and be less adherent 
to self-care behaviors than patients who are not depressed (J. O. Prochaska, 2008). Pain has been 
found to limit a person’s ability to perform self-management behaviors (Krein, Heisler, Piette, 
Makki, & Kerr, 2005). Obesity increases the incidence of insulin resistance, hypertension, 
dyslipidemia, and cardiovascular disease (DeFronzo & Ferrannini, 1991). These group 
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differences could have contributed to diminished response to the intervention when compared to 
the usual care group.  
While this study did not measure improvements to the process of providing healthcare, an 
unexpected healthcare system improvement was found. Traditionally, DGMVs have been 
delivered by physicians with the assistance of nurses or diabetes educators in fee for service 
healthcare organizations. The intervention studied here employed a Nurse Practitioner and a 
PharmD who is a Diabetes Educator. This innovative collaborative approach to deliver care 
resulted in urine microalbumin being measured and charted more frequently in the subjects who 
attended DGMVs. Having the entire picture of the patients health status by reviewing previously 
charted biophysical outcomes of care allows the healthcare team to make more informed 
decisions regarding the future care of the patient (Honoré, 2010). Thus, this finding suggests that 
a collaborative approach may improve the process of providing care even if biophysical 
outcomes of care remained essentially unchanged for both participants of DGMVs and usual care 
patients.  
Implications for Practice 
Clinical outcomes associated with group visits have been documented to include 
decreased or stable HgA1C, decreased cardiovascular risk, decreased or stable BMI, decreased 
LDL, increased HDL, decreased or stable blood pressure and slowed progression of retinopathy 
(Clancy, Cope, et al., 2003). However, DGMVs were not effective in improving biophysical 
outcomes of care in the population of persons with diabetes cared for in this free clinic. In the 
future, assessment of humanistic outcomes such as quality of life improvement, improved patient 
care delivery, and improved patient satisfaction may be useful in assessing the effectiveness of 
DGMVs in this population.  The implementation of DGMVs may be a viable option for 
76 
 
improving biophysical outcomes of care in some patient populations. Prior to implementation of 
DGMVs as an intervention, assessment of both the characteristics of the patients to be cared for 
and the system in which DGMVs will take place is advised.  
The patient characteristics found in previous studies to contribute to the success of 
DGMVs as an intervention include ethnic minority groups, female gender, older age, and some 
type of health care insurance. The results of the current study suggest that other patient 
characteristics such as pre-existing multiple co-morbid conditions other than diabetes, education 
level, depression, pain, and distance to the clinic can negatively affect biophysical outcomes of 
care and the impact of DGMVs. Future interventions for this population should be tailored to 
treat people who have diabetes and multiple co-morbid conditions, depression, pain, and live 
long distances from the clinic  The addition of services from other disciplines such as social 
work or behavioral health for this population may contribute to improved outcomes.  
In addition to tailoring interventions based on patient characteristics, an assessment of the 
healthcare delivery system is necessary. This study tested an intervention that was originally 
designed to operate within a traditional healthcare delivery system. The system of interest, the 
free clinic, cannot operate in the same ways as fee for service practices. Future interventions that 
investigate changes in the healthcare delivery system are warranted. In addition to the Nurse 
Practitioner and Pharm D, other healthcare professionals are needed to address the severe 
obesity, poor physical condition, and macrovascular complications seen in this population. 
Instead of an additional health care visit that is meant to supplement individual healthcare, 
clustered care visits where a multidisciplinary health care team work together to assess, 
diagnose, treat and educate are needed (Funnell, 2004). Another idea might be the use of 
innovative technologies or the use of home care services to provide distance care and 
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individualized education for this population. Based on these study results, implementation of 
DGMVs is only suggested if the clinic is easily accessible and can provide care from multiple 
healthcare team members. New interventions will require not only a change in practice for 
primary health care providers but in the healthcare delivery system.  
Future Research 
 Future research with this population should focus on the unique needs of persons with 
diabetes who receive care in free clinics. It is clear that this population is different than those 
previously studied using DGMVs as an intervention. In 2008, the National Center for Health 
Statistics reported that 46 million individuals under the age of 65 were uninsured, which 
translates to 16.8 percent of the population of adults under the age of 65  without insurance 
(CDC, 2006). Differing characteristics of uninsured patients such as obesity, multiple co-morbid 
conditions, less education, younger age, longer driving distances, Appalachian culture, and low 
incomes provide target areas for future tailored intervention research.  
Future research should include multi-site randomized clinical trials with consistent 
measures of biophysical outcomes related to DGMVs. Randomization to treatment group would 
correct self-selection to the intervention and non-equal groups as seen in this study. Additionally, 
future research should control for the dose of the intervention and separate the researcher role 
from clinician role. While HgA1c values are reported outcome measures in most of the DGMV 
literature, other biophysical outcomes of care are inconsistently reported. Prospective studies are 
needed to evaluate the biophysical outcomes of care in persons with diabetes when innovative 
care models are used. Such biophysical outcomes include body weight, BMI, HgA1C, fasting 
blood glucose, serum creatinine, serum lipids, urine microalbumin, and blood pressure. 
Measuring and reporting consistent biophysical outcomes as suggested by the American 
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Diabetes Association will assist researchers and clinicians in comparing the impact of DGMVs 
on outcomes.  
Many factors have been implicated in affecting outcomes for persons with diabetes. This 
study only investigated biophysical outcomes of care. This study did not investigate other 
outcome measures such as improving quality of life or improvements in the process of providing 
care. Previous research has documented that those persons with diabetes who were willing 
participate in DGMVs experienced an increase in satisfaction with care, interaction with 
providers, diabetes knowledge, education, quality of life and preventive procedures and 
screenings (Trento, et al., 2001; Wagner, et al., 2001). Additionally, positive outcomes have been 
achieved in other populations with an increase in provider trust and a decrease or more effective 
use of provider time (Clancy, Cope, et al., 2003). Longitudinal studies are needed to investigate 
how improved quality of life, provider relationships, and knowledge of disease processes could 
impact long-term negative consequences of diabetes. 
Limitations 
 The study design was based on a convince sample of persons with diabetes who attended 
at a free clinic in West Virginia from May 2007 to August 18, 2009. The generalizability of 
results is limited to the specific population of the study, given that the sample consisted of 
predominantly white, middle-aged females.  Furthermore, due to the retrospective nature of the 
study, only the variables present in the chart could be collected.   
This study did not take in to consideration the barriers to attending DGMVs for this 
population.  Out of the possible 326 patients who received care at the clinic during the study 
timeframe, only 111 patients could be included in the study. The participants who were excluded 
did not have two visits within one year during the study timeframe and hence, one year 
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comparisons could not be made.  Attendance at clinic appointments was unpredictable, with the 
cancellation rate being high for many patients. Many factors have been implicated in affecting 
outcomes, such as readiness for change, lack of transportation, financial burden, culture, age, 
gender, co-morbid conditions, and knowledge.  Future prospective studies could personalize 
interventions towards individual patients and their families, cluster care, assess for readiness to 
change, and address financial burden. Such studies would address the barriers to attending 
DGMVs found in this population.   
 Another limitation is the ability of the study to examine confounding factors that may 
influence patient characteristics and biophysical outcomes of care.  Out of the possible 326 
patients who received care at the clinic during the study timeframe, only 111 patients could be 
included in the study. The participants who were excluded did not have two visits within one 
year during the study timeframe and hence, one year comparisons could not be made.  
Attendance at clinic appointments is unpredictable, with the cancellation rate being high for 
many patients. Many factors have been implicated in affecting outcomes, such as low attendance 
rates, lack of social support, financial burden, decreased access to care, culture, and knowledge.  
This study only collected demographic and outcome variables available in the chart.   
One more limitation of the study is missing data. The patients who received usual care 
had depression scores missing from 20 cases (18%).  Depression score was analyzed as a 
characteristic to describe the groups prior to intervention, not to compare the effectiveness of the 
intervention.  However, because patients with depression are more likely to experience 
complications of diabetes, have worse glycemic control, and be less adherent to self-care 
behaviors than patients who are not depressed, examining differences in depression data before 
and after intervention could be meaningful.  Microalbumin had 27% (N= 30) missing data at 
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time one and 29.7% (N= 33) missing data at time two from the entire sample.  Patients who 
attended DGMVs had no missing data in microalbumin at time one and 3 cases (2.7%) were 
missing microalbumin data at time two.  Patients who received usual care were missing 
microalbumin in 30 cases (27%) at time one and 30 cases (27%) at time two.  The observed 
power for microalbumin data may not be enough detect a significant difference in microalbumin 
in those who attended DGMVs versus usual care at time one and time two. The large amount of 
missing microalbumin data for the patients who received usual care is a limitation of the study. It 
is also noted that there is a large standard deviation in urine microalbumin. The microalbumin 
values are known to be actual patient results and not aberrant data entry mistakes. Hence, the 
values were included in the data evaluation. 
Conclusions 
The persons with diabetes who were cared for in this clinic were severely obese, with 
elevated HgA1C levels, nephropathy, and dyslipidemia. In addition to suboptimal physical 
condition, the characteristics of persons with diabetes who receive care at this free clinic such as 
multiple co-morbid conditions, less education, younger age, longer driving distances to obtain 
care, Appalachian culture, and lack of health care insurance may have contributed to the lack of 
improvement in biophysical outcomes of care in this population. DGMVs have been shown in 
the literature to improve biophysical outcomes. However, DGMV as an intervention is not 
enough to improve biophysical outcomes in this population. Interventions targeted to the unique 
characteristics of this population are needed to prevent devastating complications. Such 
interventions should not only cluster care, but also include improved access to care and access to 
an interprofessional team. The addition of services from other disciplines such as social work or 
behavioral health and the use of innovative technologies or home care services for this 
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population may contribute to improved outcomes. Longitudinal studies are needed to investigate 
not only biophysical outcomes of care but how improved quality of life, provider relationships, 
and knowledge of disease processes could impact long-term negative consequences of diabetes. 
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Appendix A: Q-Q plots for differences in means of biophysical outcomes Aim 3 
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Appendix B: Q-Q plots Aim 4 
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Appendix C: Q-Q plots for Aim 5 Usual Care  
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Appendix D: Q-Q plots for Aim 5 DGMVs 
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Appendix E: Q-Q Plots for Continuous Characteristics for Attendees of DGMVs  
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Appendix F: Q-Q Plots for Continuous Characteristics for Usual Care
al Care 
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